{"gene":"GATA6","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1998,"finding":"GATA6 lies upstream of HNF4 in a transcriptional cascade regulating visceral endoderm differentiation; GATA6-null mice lack HNF4 expression in the endoderm, and forced GATA6 expression activates the HNF4 promoter in non-endodermal cells. GATA6-null embryoid bodies fail to form a visceral endoderm layer and lack expression of GATA4, AFP, and HNF3beta.","method":"Gene targeting (GATA6-null ES cells and mice), embryoid body differentiation, promoter activation assay, chimeric mouse analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genetic loss-of-function with multiple downstream markers, promoter activation assay, and chimeric rescue experiments in a landmark study","pmids":["9832509"],"is_preprint":false},{"year":2001,"finding":"Overexpression of GATA6 in cardiomyocytes is sufficient to induce hypertrophic growth (increased cell surface area, sarcomeric organization, protein accumulation), and a dominant-negative GATA4-engrailed repressor blocks GATA6-directed transcriptional responses and agonist-induced hypertrophy, demonstrating that GATA6 is a necessary mediator of cardiomyocyte hypertrophy.","method":"Recombinant adenovirus overexpression in cardiomyocytes, dominant-negative fusion protein (GATA4-engrailed), transgenic mouse overexpression, cell surface area and protein accumulation measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function and dominant-negative loss-of-function in vitro and in vivo with multiple orthogonal phenotypic readouts","pmids":["11356841"],"is_preprint":false},{"year":2002,"finding":"GATA6 is required for differentiation of alveolar epithelial type 1 cells in the distal lung; dominant-negative GATA6-Engrailed expression abolishes type 1 cells, increases Foxp2, and attenuates surfactant protein C expression. GATA6 can trans-activate the aquaporin-5 promoter, indicating direct transcriptional control of AT1-specific genes.","method":"Dominant-negative transgenic mice (GATA6-Engrailed driven by SP-C promoter), promoter trans-activation assay","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — dominant-negative in vivo with specific cellular phenotype plus direct promoter activation assay","pmids":["11959831"],"is_preprint":false},{"year":2004,"finding":"Endoderm differentiation and endoderm-specific gene expression (including laminin 1 subunits) in embryoid bodies is controlled by FGF-induced GATA6; GATA6-transformed Lamc1-null endoderm-like cells show that laminin 1 in the basement membrane subsequently induces epiblast differentiation.","method":"GATA6 overexpression in ES cells, embryoid body differentiation, pharmacological inhibitors (dominant-negative), gene expression analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression and genetic manipulations with defined downstream markers, single lab","pmids":["15456727"],"is_preprint":false},{"year":2006,"finding":"Gata6, but not Gata4, physically interacts with Nkx2.2 (an essential islet transcription factor). Dominant-negative Gata6-Engrailed expression in the pancreatic epithelium causes pancreatic agenesis or severe reduction of all pancreatic cell types, demonstrating Gata6 is an important regulator of pancreas specification.","method":"Co-immunoprecipitation (physical interaction with Nkx2.2), dominant-negative Gata6-Engrailed transgenic mice, histological analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP for binding plus in vivo dominant-negative with cellular phenotype, single lab","pmids":["16887115"],"is_preprint":false},{"year":2006,"finding":"Compound heterozygosity for GATA4 and GATA6 null alleles causes embryonic lethality with cardiovascular defects (thin-walled myocardium, septal defects), reduced cardiomyocyte proliferation, and downregulation of MEF2C and beta-myosin heavy chain, revealing a dosage threshold for GATA4/GATA6 activity in cardiovascular gene expression.","method":"Compound heterozygous mouse genetics, histology, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with precise dosage effect, multiple cardiovascular phenotypic readouts, mechanistic downstream targets identified","pmids":["16847256"],"is_preprint":false},{"year":2008,"finding":"Gata6 regulates the temporal appearance and number of bronchioalveolar stem cells (BASCs) by suppressing canonical Wnt signaling; loss of Gata6 increases canonical Wnt signaling and causes precocious BASC expansion. Gata6 regulates expression of the non-canonical Wnt receptor Fzd2, and increased Fzd2 or decreased beta-catenin rescues lung epithelial defects in Gata6 mutants.","method":"Conditional Gata6-null lung epithelium mice, genetic rescue (Fzd2 expression, beta-catenin reduction), Wnt signaling reporter assays, postnatal Gata6 deletion","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with genetic rescue experiments, multiple orthogonal methods establishing pathway position","pmids":["18536717"],"is_preprint":false},{"year":2008,"finding":"Dynamic GATA6 expression distinguishes parietal endoderm (GATA6+) from visceral endoderm (GATA6 lost by E5.5). GATA6-null embryos fail to form a morphologically recognizable primitive endoderm layer, establishing GATA6 as essential for primitive endoderm formation at an earlier stage than previously recognized.","method":"Immunofluorescence, in situ hybridization, GATA6-null mouse embryo analysis","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — null mouse phenotype with temporal expression analysis; single lab","pmids":["18816845"],"is_preprint":false},{"year":2008,"finding":"GATA6 and FOXA2 directly bind to the Wnt6 promoter and activate its transcription, linking GATA6 to canonical WNT-β-catenin pathway activation during primitive endoderm formation in F9 teratocarcinoma cells.","method":"Chromatin immunoprecipitation, luciferase reporter assay, overexpression of Gata6 and Foxa2 in F9 cells","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assays confirming direct binding and transcriptional activation; single lab","pmids":["22607194"],"is_preprint":false},{"year":2008,"finding":"GATA6 activates calreticulin gene transcription by binding to site 1 on the calreticulin promoter (shown by EMSA and ChIP), while Evi-1 represses calreticulin and antagonizes GATA6-mediated activation at the same site.","method":"EMSA, chromatin immunoprecipitation, site-specific mutagenesis, reporter assays in neonatal cardiomyocytes and fibroblasts","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding shown by EMSA and ChIP with mutagenesis; single lab","pmids":["18303859"],"is_preprint":false},{"year":2009,"finding":"siRNA-mediated reduction of GATA6 in human ovarian surface epithelial cells causes nuclear envelope deformation, failure of cytokinesis, and formation of polyploid/aneuploid cells. Loss of the nuclear envelope protein emerin mediates these consequences; direct siRNA suppression of emerin phenocopies GATA6 loss.","method":"siRNA knockdown, flow cytometry, immunofluorescence, nuclear morphology analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with mechanistic epistasis (emerin), single lab","pmids":["19581290"],"is_preprint":false},{"year":2012,"finding":"Simultaneous pancreas-specific deletion of both Gata4 and Gata6 causes severe pancreatic agenesis due to failure of progenitor cell proliferation, defects in branching morphogenesis, and loss of CPA1+ and NEUROG3+ progenitor differentiation; single deletion of either factor yields only mild defects that resolve postnatally.","method":"Conditional double knockout mice (Pdx1-Cre; Gata4fl/fl; Gata6fl/fl), histology, immunostaining, gene expression","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated independently in two simultaneous publications with conditional genetics and multiple cellular phenotype readouts","pmids":["23006325","23006330"],"is_preprint":false},{"year":2013,"finding":"Endothelial GATA-6 directly transcriptionally regulates genes controlling vascular tone (endothelin-1, eNOS) and pro-inflammatory genes (CX3CL1, PAI-1, RhoB). Endothelial-specific Gata6 knockout mice spontaneously develop elevated pulmonary artery pressure and increased vessel muscularization, with innate immune cell infiltration.","method":"Endothelial-specific Gata6 conditional KO mice, pulmonary artery pressure measurement, histology, gene expression analysis","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-specific KO with direct target gene regulation and in vivo vascular phenotype; single lab","pmids":["23583651"],"is_preprint":false},{"year":2014,"finding":"GATA6 levels regulate timing and speed of primitive endoderm (PrE) lineage commitment in the inner cell mass; GATA6 is necessary for PrE specification by FGF signaling; quantitative single-cell imaging shows that absence of GATA6 completely abolishes PrE and that GATA6 levels interact with NANOG and FGF/ERK to determine ICM fate.","method":"Quantitative single-cell-resolution image analysis, GATA6 hypomorphic and null embryos, FGF/ERK pathway manipulation","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative imaging plus genetic dosage series with FGF pathway epistasis, multiple labs converging on same model","pmids":["24835466"],"is_preprint":false},{"year":2014,"finding":"In mouse ICM, absence of GATA6 causes all cells to adopt epiblast identity, while absence of NANOG causes all cells to adopt PrE identity; these findings support a tristable regulatory network model where ERK signaling and concentrations of Nanog, Gata6, Fgf4, and Fgfr2 control ICM cell fate.","method":"Gata6-null and Gata6+/- embryo analysis, mathematical modeling, FGF/Erk pathway manipulation","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with mathematical modeling, single lab with supporting modeling","pmids":["25209243"],"is_preprint":false},{"year":2014,"finding":"GATA6 directly enhances LGR5 expression, and miR-363 downregulates GATA6 thereby suppressing LGR5 and colorectal cancer tumourigenicity. The miR-363-GATA6-LGR5 axis is required for colorectal cancer tumorigenicity.","method":"Overexpression/knockdown assays, luciferase reporter assay (miR-363 targeting GATA6 3'UTR), in vivo xenograft","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay validating direct targeting, in vivo xenograft, single lab","pmids":["24452072"],"is_preprint":false},{"year":2014,"finding":"GATA6 and GATA4 maintain pancreatic endoderm identity in part by repressing hedgehog signaling; in Gata4/Gata6 double-knockout pancreatic progenitors, hedgehog pathway components are ectopically upregulated, and GATA4/GATA6 can repress transcription through the Shh endoderm-specific enhancer MACS1, requiring GATA-binding sites within this enhancer.","method":"Double conditional KO mice (pDKO), reporter assay with MACS1 enhancer, GATA binding site mutagenesis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with enhancer mutagenesis reporter assay; single lab","pmids":["26932670"],"is_preprint":false},{"year":2014,"finding":"GATA6 is a crucial regulator of Shh expression in the hindlimb bud; conditional Gata6 deletion from developing limbs causes ectopic Shh expression and preaxial polydactyly, and forced GATA6 expression represses Shh. GATA6 binds to regulatory elements of Shh and Gli1 in limb bud chromatin and represses their expression synergistically with FOG co-factors. Loss of Shh in Gata6-null limbs prevents polydactyly, placing GATA6 upstream of Shh.","method":"Conditional Gata6 KO (Prx1-Cre), forced Gata6 expression, ChIP, luciferase reporter assay, genetic epistasis (Shh/Gata6 double conditional KO)","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO, genetic epistasis (compound mutant rescue), ChIP, and reporter assay with mutagenesis in one study","pmids":["24415953"],"is_preprint":false},{"year":2015,"finding":"Gata6 is sufficient to initiate reprogramming of multiple cell types (pluripotent and differentiated neural cells) to induced extraembryonic endoderm stem cells. ChIP-seq shows GATA6 enrichment near both pluripotency and endoderm genes, functioning as a direct repressor of pluripotency genes (Nanog, Esrrb, Sox2, Oct4) and activator of ExEn genes in a stepwise manner.","method":"Inducible Gata6 expression, cell reprogramming assays, ChIP-seq, transcriptional profiling","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus transcriptional profiling plus functional reprogramming across multiple cell types; single lab with multiple orthogonal methods","pmids":["26109048"],"is_preprint":false},{"year":2015,"finding":"Gata6 maintains acinar differentiation and suppresses KrasG12V-driven pancreatic tumorigenesis; ChIP-seq and RNA-seq show that GATA6 directly represses the EGFR pathway and inflammatory pathways in the pancreas; Gata6 ablation renders acinar cells more sensitive to KRas(G12V) and accelerates tumor development.","method":"Genetically engineered mouse models, ChIP-seq, RNA-seq, GATA6 silencing in human PDAC cells","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic model plus ChIP-seq and RNA-seq identifying direct target pathways; single lab with multiple orthogonal approaches","pmids":["25596178"],"is_preprint":false},{"year":2016,"finding":"GATA6 inhibits epithelial-mesenchymal transition (EMT) in pancreatic cancer cells in vitro and cell dissemination in vivo; GATA6 ChIP-seq and RNA-seq demonstrate direct transcriptional regulation of EMT-related genes and indirect regulation through other EMT transcription factors.","method":"GATA6 silencing and overexpression in PDAC cell lines, ChIP-seq, RNA-seq, in vivo dissemination assay","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function plus genome-wide ChIP-seq and RNA-seq in primary patient samples; single lab with multiple orthogonal methods","pmids":["27325420"],"is_preprint":false},{"year":2016,"finding":"Gata6 controls the renewal of rapidly proliferating hair follicle matrix progenitor cells by protecting against DNA damage associated with proliferation; Gata6 stimulates Edaradd expression and NF-κB pathway activation, and Edaradd rescues DNA damage, cell survival, proliferation, and MCM10 expression in Gata6-null keratinocytes.","method":"Conditional Gata6 KO mice, cultured keratinocyte rescue experiments with Edaradd, DNA damage assays, gene expression analysis","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO in vivo with mechanistic rescue (Edaradd), single lab","pmids":["27908934"],"is_preprint":false},{"year":2017,"finding":"Gata6 controls the identity of the sebaceous duct lineage and specifies a lineage switch between sebocytes and SD cells; during wound healing, differentiated Gata6+ cells migrate from the sebaceous duct into the interfollicular epidermis and dedifferentiate, acquiring long-term self-renewal ability and multilineage differentiation capacity.","method":"Conditional Gata6 KO mice, lineage tracing, live imaging, clonogenic assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with lineage tracing and functional self-renewal assays; published in high-impact journal with multiple methods","pmids":["28504705"],"is_preprint":false},{"year":2017,"finding":"GATA6 is required for normal insulin biosynthesis and secretion in adult β-cells; pancreas-specific Gata6 inactivation causes glucose intolerance, decreased insulin content, impaired insulin secretion, and ultrastructural abnormalities in β-cells. Pdx1 expression in adult β-cells depends on GATA-binding sites, and GATA6 loss greatly affects β-cell-specific gene expression.","method":"Pancreas-specific Gata6 KO mice, glucose tolerance testing, insulin secretion assays, electron microscopy, transgenic reporter mice with GATA site mutations","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with functional metabolic readouts, ultrastructural analysis, and reporter assay with GATA site mutation; single lab with multiple orthogonal methods","pmids":["29263149"],"is_preprint":false},{"year":2017,"finding":"GATA6 and Sp1 interact and cooperatively activate Aqp5 transcription via histone H3 acetylation; GATA6 competes with HDAC3 for Sp1 binding, and p300 modulates H3 acetylation through interactions with GATA6/Sp1. GATA6 knockdown decreases AQP5 expression in alveolar epithelial cells.","method":"siRNA knockdown, HDAC inhibitor treatment, Co-IP (GATA6/Sp1/p300/HDAC3 interactions), ChIP for histone acetylation, reporter assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, and reporter assays with knockdown; single lab with multiple biochemical methods","pmids":["28615712"],"is_preprint":false},{"year":2018,"finding":"Phosphorylation of GATA6 at a conserved serine residue (S264) by Erk1/2 is required for GATA6 to activate its own promoter and drive a positive feedback loop for primitive endoderm differentiation; S264 mutations drastically impair GATA6's ability to activate its own promoter in ES cells.","method":"Gata6-H2BGFP knock-in mouse, ES cell differentiation, site-directed mutagenesis of S264, promoter activation assay","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of specific phosphorylation site with functional promoter assay and in vivo reporter mouse; single lab with mechanistic precision","pmids":["29454706"],"is_preprint":false},{"year":2018,"finding":"Gata6 haploinsufficiency causes highly penetrant right-left-type bicuspid aortic valve in mice. Mechanistically, Gata6 haploinsufficiency disrupts valve remodeling and extracellular matrix composition through dysregulation of MMP9. Cell-specific inactivation reveals that GATA6 is required specifically in secondary heart field (Isl-1-positive) myocytes, not endothelial or neural crest cells, for aortic valve formation.","method":"Gata6 heterozygous mice, cell-specific conditional KO (Isl-1-Cre, endothelial-Cre, neural crest-Cre), MMP9 expression analysis, human GWAS validation","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cell-specific conditional KOs establishing precise cellular requirement, mechanistic target (MMP9), and human genetic validation","pmids":["29567669"],"is_preprint":false},{"year":2018,"finding":"In endometriosis, GATA6 is necessary for CYP17A1-mediated conversion of progesterone to androstenedione in endometriotic cells, and simultaneous expression of both GATA6 and NR5A1 is required and sufficient to activate all five steroidogenic genes (HSD3B2, CYP17A1, CYP19A1 and others) and estradiol production in normal endometrial stromal cells.","method":"Ectopic expression and siRNA knockdown of GATA6 and NR5A1 in endometrial and endometriotic stromal cells, estradiol ELISA, RT-qPCR, western blot","journal":"Reproductive sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with functional estradiol output assay; single lab","pmids":["29402198"],"is_preprint":false},{"year":2019,"finding":"GATA6 cooperates with EOMES/SMAD2/3 to regulate cardinal endoderm gene expression at the genome-wide level; GATA6-null human PSCs fail to enter the definitive endoderm lineage, while heterozygous cells show modest DE reduction, explaining the human-specific pancreatic agenesis with heterozygous GATA6 mutations.","method":"Gene-edited and patient-derived hPSCs, directed differentiation, ChIP-seq (GATA6, EOMES, SMAD2/3), RNA-seq, flow cytometry","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq for three factors, isogenic GATA6-null and heterozygous hPSCs with directed differentiation, multiple orthogonal methods","pmids":["30629940"],"is_preprint":false},{"year":2019,"finding":"GATA6 directly upregulates CD137L (TNFSF9) expression in cutaneous T-cell lymphoma cells by binding to its promoter; GATA6 overexpression in CTCL is driven by DNA hypomethylation and histone acetylation, and GATA6 inhibition decreases CTCL cell survival and in vivo growth.","method":"ChIP assay, luciferase reporter assay, shRNA knockdown, flow cytometry, in vivo mouse xenograft","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with functional knockdown in vivo; single lab","pmids":["30194255"],"is_preprint":false},{"year":2019,"finding":"GATA6 directly transcribes miR-520b (shown by luciferase reporter and ChIP assays), and miR-520b suppresses CREB1, establishing a GATA6/miR-520b/CREB1 axis that suppresses gastric cancer cell migration and metastasis.","method":"Luciferase reporter assay, ChIP, overexpression/knockdown, in vivo metastasis model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay confirming direct binding with in vivo functional validation; single lab","pmids":["30674866"],"is_preprint":false},{"year":2019,"finding":"GATA6 directly binds the promoter of the PKM gene and regulates PKM2 transcription; GATA6 silencing in HCC cells promotes glycolytic metabolism, EMT, tumorigenicity, and self-renewal via PKM2 upregulation.","method":"ChIP assay, gene knockdown and overexpression, metabolic assays (glucose uptake), in vivo tumorigenicity","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter binding, functional metabolic and tumorigenic phenotype; single lab","pmids":["30834518"],"is_preprint":false},{"year":2019,"finding":"GATA6 physically interacts with LOXL2 (the scavenger receptor cysteine-rich domain of LOXL2 interacts with GATA6), and this complex promotes VEGFA mRNA expression and protein secretion, driving angiogenesis and tube formation in cholangiocarcinoma.","method":"Co-immunoprecipitation, western blot, RT-qPCR, ELISA, tube formation assay, in vivo xenograft","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP for physical interaction plus functional angiogenesis assays; single lab","pmids":["31322171"],"is_preprint":false},{"year":2019,"finding":"Gata4 directly represses Gata6 transcription through responsive repressive sites within 1 kb upstream of the Gata6 transcription start site, shown by ChIP-qPCR and luciferase reporter assay; enhanced Gata6 expression in Gata4 heterozygous SHF cells contributes to outflow tract defects.","method":"ChIP-qPCR, luciferase reporter assay, Gata4 heterozygous mouse model, gene expression analysis","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with mutagenesis plus in vivo genetic model; single lab","pmids":["31120883"],"is_preprint":false},{"year":2020,"finding":"GATA6 is a pioneer factor in cardiac development: it regulates SMYD1 (which activates HAND2) and KDR (which with HAND2 orchestrates outflow tract formation). GATA6 loss-of-function variants perturb cardiac and endoderm lineage genes directing PDX1/pancreatic development. An exon 4 GATA6 missense variant causes ectopic pioneer activities, reducing GATA4, FOXA1/2, and PDX1 and increasing retinoic acid signaling promoting diaphragm development.","method":"Isogenic iPSC cardiomyocyte differentiation, RNA-seq, ATAC-seq (chromatin accessibility), ChIP-seq, GATA6 LoF and missense variant comparison","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — isogenic iPSC system with GATA6 LoF and missense variants, genome-wide ATAC-seq and RNA-seq, multiple mechanistic targets identified; single lab with multiple orthogonal methods","pmids":["33054971"],"is_preprint":false},{"year":2020,"finding":"EZH2 transcriptionally represses GATA6 in PDAC via H3K27 methylation; genetic or pharmacologic EZH2 depletion increases GATA6 expression and induces a classical gene signature, while GATA6 re-ablation in EZH2-deficient cells rescues invasive capacity and basal gene signature.","method":"ChIP-seq (EZH2 on GATA6 locus), RNA-seq, GATA6 knockdown in EZH2-depleted cells, transgenic PDAC models","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus RNA-seq plus epistatic rescue experiment establishing direct epigenetic repression; single lab with multiple orthogonal methods","pmids":["32907838"],"is_preprint":false},{"year":2020,"finding":"GATA6 directly binds the promoter of VEGF-C at its promoter region and acts as a transcriptional repressor; loss of GATA6 in bladder cancer (via promoter hypermethylation) leads to VEGF-C upregulation, promoting lymphangiogenesis and lymph node metastasis.","method":"ChIP assay, promoter binding assay, GATA6 reconstitution and knockdown, in vivo lymph node metastasis model","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct promoter binding with functional in vivo metastasis readout; single lab","pmids":["32103545"],"is_preprint":false},{"year":2020,"finding":"GATA6 directly upregulates MUC1 expression by binding to GATA-motifs at positions -1584 and -1456 in the MUC1 promoter; MUC1 then binds to β-catenin and increases nuclear β-catenin levels, driving EMT and metastasis in cholangiocarcinoma.","method":"ChIP-seq, luciferase reporter assay with point-mutant GATA sites, co-immunoprecipitation (MUC1/β-catenin), knockdown/overexpression, in vivo metastasis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus reporter mutagenesis plus Co-IP for complex; single lab","pmids":["33060563"],"is_preprint":false},{"year":2020,"finding":"GATA6 controls insulin biosynthesis/secretion in adult β-cells and lung specification from human PSCs: knockdown of GATA6 during endoderm patterning increases NKX2.1+ lung progenitors, while GATA6 ablation impairs terminal lung differentiation; transgenic GATA6 expression skews development toward liver fate at the expense of lung progenitors, revealing a dosage effect.","method":"GATA6 knockdown and null hPSC lines, directed differentiation to lung progenitors, flow cytometry, gene expression analysis","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GATA6 null and knockdown hPSC differentiation with functional lung progenitor output; single lab","pmids":["29889101"],"is_preprint":false},{"year":2020,"finding":"TET2 marks the GATA6 locus with 5-hydroxymethylcytosine (5hmc) to maintain classical PDAC phenotype; SMAD4 directly supports TET2 levels, and loss of SMAD4 reduces 5hmc, GATA6 expression, and promotes squamous-like tumors. Restoring TET2 stability with metformin/vitamin C restores 5hmc and GATA6 levels and reverts squamous-like phenotype in vitro and in vivo.","method":"Oxidative bisulfite sequencing (genome-wide 5hmc and 5mc mapping), in vivo pharmacological rescue, bioinformatics iCluster","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide epigenetic mapping with in vivo pharmacological rescue; single lab","pmids":["33915173"],"is_preprint":false},{"year":2021,"finding":"HDAC1/2 suppress GATA6 expression by promoting STAT3 acetylation, which enhances DNMT1 binding to STAT3 and leads to hypermethylation of the GATA6 promoter CpG region (+140/+255); blocking STAT3 acetylation at Lys685 disrupts DNMT1-STAT3 interaction and reverses GATA6 promoter methylation, demonstrating an epigenetic regulatory mechanism for GATA6 in endothelial cells.","method":"Romidepsin treatment, HDAC1/2 siRNA, methylation-specific PCR, ChIP (STAT3 enrichment at GATA6 promoter), STAT3 Lys685Arg mutation, Co-IP (DNMT1-STAT3), in vivo atherosclerosis model","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, Co-IP, and mutagenesis with in vivo validation; single lab with multiple biochemical methods","pmids":["33859766"],"is_preprint":false},{"year":2021,"finding":"A GATA6-centered gene regulatory network involving HNF1A and HNF4A controls PDAC subtype identity; GATA6 loss alone is necessary but not sufficient for basal program expression—concomitant loss of HNF1A and HNF4A (through epigenetic silencing) is required for the full phenotype switch. In mice, late Gata6 deletion dramatically increased metastatic rate.","method":"Dual-recombinase mouse model (Gata6LateKO), RNA-seq of primary tumor cells, human transcriptomics datasets, tissue samples","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 / Strong — novel mouse model for late-stage Gata6 deletion plus RNA-seq plus human-to-mouse validation; single lab with multiple orthogonal methods","pmids":["33846140"],"is_preprint":false},{"year":2021,"finding":"GATA6 directly activates TBX3 and EDN1 as key regulators of the sinus node genetic program (in conduction and non-conduction cells, respectively); Gata6 haploinsufficiency causes hypoplastic sinus node and rhythm abnormalities, and cell-specific deletion reveals requirements in multiple SAN lineages.","method":"Gata6 heterozygous and cell-specific conditional KO mice, ECG recording, histology, chromatin binding and transcriptional activation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — haploinsufficiency and cell-specific KO with direct target activation (TBX3, EDN1) and in vivo electrophysiology; single lab with multiple orthogonal methods","pmids":["33443158"],"is_preprint":false},{"year":2022,"finding":"GATA6 and NANOG co-bind at the vast majority of epiblast and PrE enhancers both in embryonic stem cells and in blastocysts; upon GATA6 induction, co-binding is followed by eviction of Epi TFs, rapid chromatin remodeling and remodeling of enhancer-promoter contacts to establish PrE lineage while repressing Epi fate.","method":"Inducible GATA6 in ES cells, ChIP-seq (GATA6 and NANOG), ATAC-seq, Hi-C/4C (enhancer-promoter contacts), blastocyst ChIP","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq, chromatin accessibility, and 3D chromatin contacts in both ES cells and embryos; single lab with multiple orthogonal genome-wide methods","pmids":["35871075"],"is_preprint":false},{"year":2022,"finding":"EP300 (p300) histone acetyltransferase directly supports GATA6 expression; loss of EP300 downregulates GATA6 and silences the GATA6-regulated differentiation program, causing a phenotypic switch from classical to basal-like/squamous PDAC subtype and resistance to PORCN (Wnt) inhibitors.","method":"In vivo CRISPR screen, EP300 knockdown/KO, GATA6 overexpression rescue, RNA-seq, chromatin accessibility mapping","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo CRISPR screen identifying EP300, epistatic rescue with GATA6 re-expression, RNA-seq; single lab with multiple orthogonal methods","pmids":["35536676"],"is_preprint":false},{"year":2022,"finding":"Endothelial Gata6 deletion reduces atherosclerosis by decreasing monocyte infiltration and pro-inflammatory macrophage formation; Cmpk2 and Ccl5 are identified as direct target genes of GATA6 in endothelial cells mediating these effects through the CMPK2-Nlrp3 pathway.","method":"EC-specific Gata6 KO in ApoeKO mice, endothelial AAV9-Cmpk2-shRNA delivery, ChIP (direct target identification), monocyte adhesion and migration assays, lesion quantification","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-specific KO with ChIP for direct targets and epistatic in vivo rescue; single lab","pmids":["37339559"],"is_preprint":false},{"year":2023,"finding":"Gata6 deletion from the brown fat lineage causes a striking loss of brown adipose tissue, identifying GATA6 as a crucial regulator of brown adipocyte development; GATA6 marks brown adipogenic progenitor cells.","method":"Single-cell gene expression analysis, immunostaining, lineage tracing, conditional Gata6 KO in brown fat lineage","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with lineage tracing and single-cell RNA-seq; single lab","pmids":["37647897"],"is_preprint":false},{"year":2023,"finding":"SIRT6 inhibits GATA6 transcription by deacetylating and increasing degradation of the transcription factor Nkx2.5 (which would otherwise activate GATA6); GATA6 in turn impedes ATM-mediated DNA damage repair, leading to accelerated VSMC senescence and osteogenic differentiation. Gata6 knockdown (via AAV-shRNA) inhibits arterial calcification in CKD mice.","method":"SIRT6-transgenic mice, Gata6 AAV-shRNA knockdown, in vitro gain/loss-of-function, co-immunoprecipitation (SIRT6-Nkx2.5), DNA damage repair assays (ATM pathway)","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP for interaction, AAV-mediated in vivo knockdown, mechanistic epistasis (SIRT6/Nkx2.5/GATA6/ATM); single lab","pmids":["37914087"],"is_preprint":false},{"year":2012,"finding":"GATA-6 and NF-κB bind to specific sites on the CPI-17 promoter and upregulate CPI-17 expression in an additive manner in bladder smooth muscle cells; CPI-17 inhibits myosin light chain phosphatase, thereby regulating Ca2+ sensitization and contractile force maintenance in smooth muscle.","method":"Promoter binding assays, EMSA, GATA-6 siRNA knockdown, NF-κB KO mice, smooth muscle force measurement","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter binding assays with KO mice and functional contractility readout; single lab","pmids":["23275439"],"is_preprint":false},{"year":2016,"finding":"Gain-of-function GATA6 variants (R585L, P91S, A177T) show markedly upregulated transcriptional activity in reporter assays and enhanced activation of ANP and alpha-MHC promoters when co-expressed with GATA4 and MEF2C, demonstrating that gain-of-function GATA6 mutations can drive atrial fibrillation.","method":"Whole exome sequencing, luciferase reporter assay with wild-type and mutant GATA6 constructs, co-expression with GATA4/MEF2C","journal":"Heart rhythm","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reporter assay establishing gain-of-function for three variants; single lab","pmids":["27756709"],"is_preprint":false},{"year":2015,"finding":"REG4 is a direct transcriptional target of GATA6; GATA6-mediated activation of REG4 enhances adherent growth of colon cancer cells, while LGR5 activation by GATA6 drives clonogenicity, with both being suppressed by miR-363 targeting of GATA6.","method":"GATA6 overexpression/knockdown, miR-363 overexpression, gene expression analysis, colon cancer cell proliferation/tumorigenicity assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct transcriptional target identification with functional rescue; single lab","pmids":["26387746"],"is_preprint":false}],"current_model":"GATA6 is a zinc-finger transcription factor and pioneer factor that directly binds regulatory elements of numerous target genes (HNF4, Shh, VEGF-C, MUC1, TBX3, EDN1, Wnt6, CPI-17, REG4, LGR5, Aqp5, PKM2, Cmpk2, Ccl5, GATA6 itself) to regulate cell fate decisions in endoderm, heart, pancreas, lung, skin, and macrophage lineages; its activity is modulated post-translationally by ERK1/2-mediated phosphorylation at S264 (required for autoactivation in primitive endoderm commitment) and epigenetically through EZH2-mediated H3K27 methylation and HDAC1/2-STAT3-DNMT1-dependent promoter methylation; it cooperates with NANOG, EOMES/SMAD2/3, FOXA2, NR5A1, Nkx2.2, p300, and FOG co-factors in context-specific transcriptional complexes, and its loss-of-function causes defects ranging from primitive endoderm and visceral endoderm failure to pancreatic agenesis, bicuspid aortic valve, sinus node hypoplasia, impaired β-cell insulin secretion, and loss of brown adipose tissue."},"narrative":{"mechanistic_narrative":"GATA6 is a zinc-finger transcription factor and chromatin pioneer factor that directs lineage commitment and tissue identity across endoderm, heart, pancreas, lung, skin, and vascular systems by binding regulatory elements of fate-determining target genes [PMID:9832509, PMID:26109048, PMID:33054971]. In the early embryo it is essential for primitive and visceral endoderm formation, acting upstream of HNF4 and within an FGF/ERK-driven tristable network where its levels, opposed by NANOG, dictate inner cell mass fate; ERK1/2 phosphorylation at S264 drives a positive-feedback autoactivation loop required for primitive endoderm commitment [PMID:9832509, PMID:24835466, PMID:25209243, PMID:29454706]. Genome-wide, GATA6 co-binds enhancers with NANOG and then evicts epiblast factors, remodeling chromatin accessibility and enhancer-promoter contacts to activate extraembryonic-endoderm genes while repressing pluripotency genes, and it cooperates with EOMES/SMAD2/3 to license definitive endoderm [PMID:35871075, PMID:26109048, PMID:30629940]. In organ development it acts combinatorially and dose-dependently with GATA4 in pancreatic specification and cardiovascular morphogenesis, repressing Hedgehog signaling through GATA sites in the Shh MACS1 enhancer and maintaining acinar and β-cell identity, with haploinsufficiency producing bicuspid aortic valve via MMP9 dysregulation and sinus node hypoplasia through loss of TBX3/EDN1 activation [PMID:23006325, PMID:23006330, PMID:26932670, PMID:24415953, PMID:29263149, PMID:29567669, PMID:33443158]. It also governs lung alveolar type-1 differentiation and Wnt restriction, hair follicle and sebaceous duct lineage identity, and brown adipocyte development [PMID:11959831, PMID:18536717, PMID:28504705, PMID:37647897]. GATA6 expression is itself tightly controlled epigenetically—supported by p300/EP300 acetylation and TET2-deposited 5hmC, and repressed by EZH2-mediated H3K27 methylation and HDAC1/2-STAT3-DNMT1-dependent promoter hypermethylation—a circuitry that toggles the classical-versus-basal subtype switch in pancreatic cancer, where GATA6 (with HNF1A/HNF4A) suppresses EGFR signaling, EMT, and tumor progression [PMID:32907838, PMID:35536676, PMID:33915173, PMID:33859766, PMID:33846140, PMID:25596178, PMID:27325420]. In the broader cancer setting GATA6 acts as a context-dependent activator or repressor of targets including LGR5, REG4, VEGF-C, MUC1, and PKM2 [PMID:24452072, PMID:26387746, PMID:32103545, PMID:33060563, PMID:30834518]. Heterozygous loss-of-function GATA6 mutations cause human pancreatic agenesis, explained by failure of definitive endoderm entry [PMID:30629940].","teleology":[{"year":1998,"claim":"Established GATA6 as a master upstream regulator of visceral endoderm differentiation, placing it atop a transcriptional cascade where no endoderm-specifying factor had been genetically ordered.","evidence":"GATA6-null ES cells/mice, embryoid body differentiation, and HNF4 promoter activation assay","pmids":["9832509"],"confidence":"High","gaps":["Did not define direct vs indirect target relationships genome-wide","Mechanism of GATA6 chromatin engagement not addressed"]},{"year":2001,"claim":"Showed GATA6 is a necessary mediator of cardiomyocyte hypertrophy, extending its role from development to adult cardiac stress responses.","evidence":"Adenoviral overexpression and dominant-negative GATA4-engrailed in cardiomyocytes plus transgenic mice","pmids":["11356841"],"confidence":"High","gaps":["Direct hypertrophic target genes not delineated","Dominant-negative does not distinguish GATA6 from GATA4 function"]},{"year":2002,"claim":"Defined GATA6 as required for alveolar type-1 cell differentiation and direct activator of AT1-specific genes, expanding its lineage scope to distal lung.","evidence":"Dominant-negative GATA6-Engrailed transgenic mice and aquaporin-5 promoter trans-activation","pmids":["11959831"],"confidence":"High","gaps":["Dominant-negative may affect other GATA factors","Endogenous GATA6 loss-of-function in lung not tested here"]},{"year":2006,"claim":"Identified GATA6 as required for pancreas specification and a physical Nkx2.2 partner, establishing tissue-specific protein interactions underlying its pancreatic role.","evidence":"Co-IP with Nkx2.2 and dominant-negative Gata6-Engrailed transgenic mice with histology","pmids":["16887115"],"confidence":"Medium","gaps":["Co-IP not reciprocally validated for direct binding","Dominant-negative does not isolate endogenous GATA6 requirement"]},{"year":2006,"claim":"Revealed a GATA4/GATA6 dosage threshold for cardiovascular gene expression, demonstrating combinatorial and redundant function between the two factors.","evidence":"Compound heterozygous mouse genetics with histology and downstream marker analysis (MEF2C, beta-MHC)","pmids":["16847256"],"confidence":"High","gaps":["Direct vs indirect regulation of MEF2C/beta-MHC not resolved","Cell-type specificity of dosage requirement not mapped"]},{"year":2008,"claim":"Connected GATA6 to Wnt signaling control in lung stem cell dynamics and to direct activation of canonical Wnt components in endoderm, defining a pathway-level node.","evidence":"Conditional lung Gata6-null mice with genetic rescue (Fzd2, beta-catenin); ChIP and reporter on Wnt6 promoter in F9 cells","pmids":["18536717","22607194"],"confidence":"High","gaps":["Context-dependent canonical vs non-canonical Wnt switching mechanism unclear","F9 cell findings need in vivo validation"]},{"year":2009,"claim":"Linked GATA6 to nuclear envelope integrity and genome stability via emerin, an unexpected role beyond classical lineage transcription.","evidence":"siRNA knockdown in ovarian surface epithelial cells with emerin epistasis and nuclear morphology analysis","pmids":["19581290"],"confidence":"Medium","gaps":["Direct transcriptional control of emerin by GATA6 not shown by binding data","Single cell-type, no in vivo confirmation"]},{"year":2012,"claim":"Demonstrated that combined GATA4/GATA6 loss causes pancreatic agenesis through progenitor proliferation and morphogenesis failure, defining the genetic basis for human GATA6-associated pancreatic agenesis.","evidence":"Conditional double-knockout mice with histology and progenitor marker analysis (two simultaneous publications)","pmids":["23006325","23006330"],"confidence":"High","gaps":["Direct target genes driving proliferation defect not identified here","Relative GATA4 vs GATA6 contribution not separated"]},{"year":2013,"claim":"Showed endothelial GATA6 directly regulates vascular tone and inflammatory genes, extending its function to vascular homeostasis.","evidence":"Endothelial-specific Gata6 conditional KO mice with pulmonary artery pressure and target gene analysis","pmids":["23583651"],"confidence":"Medium","gaps":["Direct binding to all named targets not all demonstrated","Single lab, mechanism of inflammatory recruitment incomplete"]},{"year":2014,"claim":"Quantitatively defined GATA6 as a dose-sensitive determinant of inner cell mass fate within a tristable NANOG/FGF/ERK network, resolving how PrE versus epiblast identity is set.","evidence":"Single-cell imaging and Gata6 dosage series with FGF/ERK manipulation; mathematical modeling","pmids":["24835466","25209243"],"confidence":"High","gaps":["Direct molecular target of GATA6 enacting fate switch not isolated","Quantitative thresholds may be model-system specific"]},{"year":2014,"claim":"Identified GATA6 as a crucial regulator of Shh expression in the limb bud, repressing Shh/Gli1 with FOG co-factors and acting upstream of polydactyly phenotypes.","evidence":"Conditional Gata6 KO, forced expression, ChIP, reporter assay, and Shh/Gata6 genetic epistasis","pmids":["24415953"],"confidence":"High","gaps":["Mechanism of FOG-dependent repression switch not detailed","How GATA6 chooses activation vs repression at different loci unclear"]},{"year":2014,"claim":"Defined GATA6 as a direct activator of LGR5 and REG4 in colorectal cancer, downregulated by miR-363, establishing a tumorigenicity axis.","evidence":"Overexpression/knockdown, luciferase reporter (miR-363/GATA6 3'UTR), and xenograft assays","pmids":["24452072","26387746"],"confidence":"Medium","gaps":["Direct ChIP binding at LGR5/REG4 promoters not all confirmed in same study","Single lineage context"]},{"year":2014,"claim":"Showed GATA6/GATA4 maintain pancreatic endoderm identity by directly repressing Hedgehog through GATA sites in the Shh MACS1 enhancer.","evidence":"Double conditional KO and MACS1 enhancer reporter with GATA-site mutagenesis","pmids":["26932670"],"confidence":"Medium","gaps":["Endogenous occupancy at MACS1 not shown by ChIP here","Single lab"]},{"year":2015,"claim":"Established GATA6 as a pioneer factor sufficient to reprogram cells to extraembryonic endoderm, acting as direct repressor of pluripotency genes and activator of endoderm genes.","evidence":"Inducible Gata6, reprogramming assays, ChIP-seq, and transcriptional profiling","pmids":["26109048"],"confidence":"High","gaps":["Order of repression vs activation events not fully temporally resolved","Pioneer chromatin-opening mechanism characterized later"]},{"year":2015,"claim":"Defined GATA6 as a tumor suppressor in pancreatic cancer that directly represses EGFR and inflammatory pathways to maintain acinar identity.","evidence":"GEMMs with KrasG12V, ChIP-seq, RNA-seq, and human PDAC cell silencing","pmids":["25596178"],"confidence":"High","gaps":["Mechanism of repression at EGFR pathway loci not detailed","Cofactors mediating repression not defined"]},{"year":2016,"claim":"Showed GATA6 inhibits EMT and dissemination in PDAC through direct and indirect transcriptional control of EMT genes, reinforcing its differentiation-maintaining role.","evidence":"Gain/loss-of-function in PDAC cells, ChIP-seq, RNA-seq, in vivo dissemination","pmids":["27325420"],"confidence":"High","gaps":["Indirect EMT TF regulation not fully mapped","Patient-stratification implications not tested clinically"]},{"year":2016,"claim":"Identified gain-of-function GATA6 variants that enhance transcriptional activity and can drive atrial fibrillation, complementing loss-of-function disease mechanisms.","evidence":"Whole exome sequencing and reporter assays with GATA4/MEF2C co-expression","pmids":["27756709"],"confidence":"Medium","gaps":["Reporter assay does not establish in vivo arrhythmogenic mechanism","Limited to three variants, single lab"]},{"year":2016,"claim":"Defined GATA6 control of hair follicle matrix progenitor renewal via Edaradd/NF-kB to protect proliferating cells from DNA damage, extending its role to epidermal stem cells.","evidence":"Conditional KO and keratinocyte rescue with Edaradd; DNA damage assays","pmids":["27908934"],"confidence":"Medium","gaps":["Direct GATA6 binding at Edaradd not shown","Single lab"]},{"year":2017,"claim":"Established GATA6 as the lineage-identity determinant of the sebaceous duct and a driver of cellular dedifferentiation and self-renewal during wound healing.","evidence":"Conditional KO, lineage tracing, live imaging, clonogenic assays","pmids":["28504705"],"confidence":"High","gaps":["Transcriptional targets enforcing SD identity not defined","Mechanism of dedifferentiation gain unclear"]},{"year":2017,"claim":"Defined GATA6 as required for adult β-cell insulin biosynthesis and secretion, acting through GATA-dependent Pdx1 expression.","evidence":"Pancreas-specific KO with glucose tolerance, insulin assays, EM, and GATA-site mutant reporter mice","pmids":["29263149"],"confidence":"High","gaps":["Full β-cell target gene network not mapped","Direct vs indirect Pdx1 regulation partially resolved"]},{"year":2017,"claim":"Showed GATA6 cooperates with Sp1 and p300 to activate Aqp5 via histone acetylation, competing with HDAC3, illustrating its coactivator-recruitment mechanism.","evidence":"Co-IP (GATA6/Sp1/p300/HDAC3), ChIP for acetylation, and reporter assays","pmids":["28615712"],"confidence":"Medium","gaps":["Co-IP interactions not reciprocally validated for direct contact","Single lab"]},{"year":2017,"claim":"Implicated GATA6 with NR5A1 in steroidogenesis in endometriotic cells, broadening its role to local estrogen production in disease.","evidence":"Ectopic expression and siRNA of GATA6/NR5A1 with estradiol output assays","pmids":["29402198"],"confidence":"Medium","gaps":["Direct promoter binding at steroidogenic genes not shown","Single lab, in vitro only"]},{"year":2018,"claim":"Resolved how GATA6 sustains its own expression: ERK1/2 phosphorylation at S264 enables autoactivation, providing the post-translational switch for primitive endoderm commitment.","evidence":"Gata6-H2BGFP knock-in mouse, S264 site-directed mutagenesis, and promoter activation assay","pmids":["29454706"],"confidence":"High","gaps":["Direct demonstration of ERK phosphorylation at S264 in vivo limited","Other phosphosites not surveyed"]},{"year":2018,"claim":"Defined the precise cellular requirement for GATA6 in bicuspid aortic valve via secondary-heart-field myocytes and MMP9-dependent valve remodeling, with human genetic validation.","evidence":"Haploinsufficient and cell-specific conditional KO mice, MMP9 analysis, human GWAS","pmids":["29567669"],"confidence":"High","gaps":["Direct GATA6 regulation of MMP9 not shown by binding","Mechanism of ECM dysregulation incomplete"]},{"year":2019,"claim":"Showed GATA6 cooperates genome-wide with EOMES/SMAD2/3 to license definitive endoderm, mechanistically explaining human heterozygous GATA6 pancreatic agenesis.","evidence":"Isogenic and patient-derived hPSCs, directed differentiation, ChIP-seq of three factors, RNA-seq","pmids":["30629940"],"confidence":"High","gaps":["Dosage threshold for human DE entry not precisely quantified","Cooperative complex assembly mechanism not structurally resolved"]},{"year":2019,"claim":"Expanded the GATA6 cancer target repertoire (CD137L, miR-520b/CREB1, PKM2) and showed context-dependent activator/repressor behavior across tumor types.","evidence":"ChIP, reporter assays, knockdown/overexpression, in vivo metastasis/tumorigenicity models","pmids":["30194255","30674866","30834518"],"confidence":"Medium","gaps":["Cofactors determining activation vs repression at these loci unknown","Each target validated in single tumor context"]},{"year":2019,"claim":"Demonstrated GATA6 is itself repressed by GATA4 through proximal repressive sites, revealing cross-regulation between the two GATA factors in heart development.","evidence":"ChIP-qPCR, reporter assay, and Gata4 heterozygous mice","pmids":["31120883"],"confidence":"Medium","gaps":["Mechanism of GATA4-mediated repression unclear","Single lab"]},{"year":2019,"claim":"Identified a GATA6-LOXL2 physical complex driving VEGFA-dependent angiogenesis, an example of non-transcription-factor partnership.","evidence":"Co-IP, RT-qPCR, ELISA, tube formation, xenograft in cholangiocarcinoma","pmids":["31322171"],"confidence":"Medium","gaps":["Co-IP not reciprocally confirmed for direct binding","How LOXL2 modulates GATA6 activity unclear"]},{"year":2020,"claim":"Characterized GATA6 as a cardiac pioneer factor regulating SMYD1/HAND2/KDR for outflow tract formation, and showed a missense variant confers ectopic pioneer activity altering lineage output.","evidence":"Isogenic iPSC cardiomyocytes, RNA-seq, ATAC-seq, ChIP-seq comparing LoF and missense variants","pmids":["33054971"],"confidence":"High","gaps":["Mechanism of ectopic pioneer activity of missense variant not fully defined","In vivo correlate of iPSC findings limited"]},{"year":2020,"claim":"Established that GATA6 expression is epigenetically silenced by EZH2 (H3K27me) to enforce the basal PDAC program, with GATA6 re-ablation confirming its functional importance.","evidence":"EZH2 ChIP-seq at GATA6 locus, RNA-seq, and epistatic GATA6 knockdown in EZH2-deficient cells","pmids":["32907838"],"confidence":"High","gaps":["Trigger for EZH2 recruitment to GATA6 locus unknown","Reversibility window in patients untested"]},{"year":2020,"claim":"Identified additional context-dependent GATA6 repression targets (VEGF-C in bladder cancer, MUC1/beta-catenin axis in cholangiocarcinoma) and dose-sensitive lung-versus-liver fate control.","evidence":"ChIP, reporter mutagenesis, Co-IP, knockdown/overexpression, in vivo metastasis; hPSC lung differentiation","pmids":["32103545","33060563","29889101"],"confidence":"Medium","gaps":["Switch between activator and repressor function not mechanistically explained","Each target in single tissue context"]},{"year":2021,"claim":"Defined a GATA6/HNF1A/HNF4A regulatory network controlling PDAC subtype identity, showing GATA6 loss is necessary but not sufficient for the basal switch.","evidence":"Dual-recombinase late-deletion mouse model, RNA-seq, human transcriptomics validation","pmids":["33846140"],"confidence":"High","gaps":["Hierarchy among GATA6, HNF1A, HNF4A not fully ordered","Therapeutic exploitation not addressed"]},{"year":2021,"claim":"Showed epigenetic control of GATA6 levels in vascular and tumor contexts: HDAC1/2-STAT3-DNMT1 promoter hypermethylation represses it, while TET2-deposited 5hmC (SMAD4-supported) maintains it.","evidence":"MSP, ChIP, Co-IP, STAT3 K685 mutation, oxidative bisulfite sequencing, in vivo pharmacological rescue","pmids":["33859766","33915173"],"confidence":"Medium","gaps":["Cross-talk between activating and repressive marks at GATA6 locus unresolved","Single lab per mechanism"]},{"year":2022,"claim":"Resolved the pioneer mechanism: GATA6 co-binds enhancers with NANOG then evicts epiblast factors and remodels chromatin and enhancer-promoter contacts to flip ICM cells to PrE fate.","evidence":"Inducible GATA6 ES cells and blastocysts, ChIP-seq, ATAC-seq, Hi-C/4C","pmids":["35871075"],"confidence":"High","gaps":["Molecular trigger for epiblast-TF eviction not identified","Kinetics of chromatin remodeling at single-cell level limited"]},{"year":2022,"claim":"Identified EP300/p300 as a direct positive regulator of GATA6 expression whose loss drives the classical-to-basal PDAC switch and Wnt-inhibitor resistance.","evidence":"In vivo CRISPR screen, EP300 KO, GATA6 overexpression rescue, RNA-seq, chromatin accessibility","pmids":["35536676"],"confidence":"High","gaps":["Whether EP300 acts directly at GATA6 locus vs broadly not fully resolved","Clinical reversal strategy untested"]},{"year":2021,"claim":"Established GATA6 as a direct activator of the sinus node program through TBX3 and EDN1, with haploinsufficiency causing hypoplastic sinus node and arrhythmia.","evidence":"Haploinsufficient and cell-specific KO mice, ECG, histology, chromatin binding and activation assays","pmids":["33443158"],"confidence":"High","gaps":["Lineage-specific cofactors at TBX3/EDN1 not defined","Human relevance via genetics not tested here"]},{"year":2023,"claim":"Extended GATA6 roles to vascular inflammation/atherosclerosis (direct Cmpk2/Ccl5 targets via CMPK2-Nlrp3), brown adipocyte development, and vascular calcification (SIRT6-Nkx2.5-GATA6-ATM axis).","evidence":"Cell-specific KO, ChIP, AAV knockdown/rescue, lineage tracing, single-cell RNA-seq, Co-IP","pmids":["37339559","37647897","37914087"],"confidence":"Medium","gaps":["Direct binding for all named targets not uniformly demonstrated","Each context single lab"]},{"year":2012,"claim":"Showed GATA6 with NF-kB activates CPI-17 in smooth muscle to regulate calcium sensitization and contractile force, a role in smooth muscle physiology.","evidence":"Promoter binding assays, EMSA, GATA6 siRNA, NF-kB KO mice, force measurement","pmids":["23275439"],"confidence":"Medium","gaps":["Additive vs cooperative mechanism with NF-kB not fully dissected","Single lab"]},{"year":null,"claim":"How GATA6 switches between transcriptional activation and repression at different loci, and what cofactor/chromatin context dictates pioneer versus classical TF behavior, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying rule for activator-vs-repressor target selection","Structural basis of GATA6 cofactor complexes not determined","Post-translational modifications beyond S264 not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,18,19,28,34,42,43]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[8,9,17,30,31,36,37]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[9,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[18,43,25]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,11,13,17,26,42,46]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,18,28,34,43]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[19,20,35,41,44]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[35,43,44]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,13,14,25]}],"complexes":[],"partners":["GATA4","NANOG","EOMES","SMAD2","FOXA2","NR5A1","SP1","EP300"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92908","full_name":"Transcription factor GATA-6","aliases":["GATA-binding factor 6"],"length_aa":595,"mass_kda":60.0,"function":"Transcriptional activator (PubMed:19666519, PubMed:22750565, PubMed:22824924, PubMed:27756709). Regulates SEMA3C and PLXNA2 (PubMed:19666519). Involved in gene regulation specifically in the gastric epithelium (PubMed:9315713). May regulate genes that protect epithelial cells from bacterial infection (PubMed:16968778). Involved in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression (By similarity). Binds to BMP response element (BMPRE) DNA sequences within cardiac activating regions (By similarity). In human skin, controls several physiological processes contributing to homeostasis of the upper pilosebaceous unit. Triggers ductal and sebaceous differentiation as well as limits cell proliferation and lipid production to prevent hyperseborrhoea. Mediates the effects of retinoic acid on sebocyte proliferation, differentiation and lipid production. Also contributes to immune regulation of sebocytes and antimicrobial responses by modulating the expression of anti-inflammatory genes such as IL10 and pro-inflammatory genes such as IL6, TLR2, TLR4, and IFNG. Activates TGFB1 signaling which controls the interfollicular epidermis fate (PubMed:33082341)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q92908/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GATA6","classification":"Not Classified","n_dependent_lines":26,"n_total_lines":1208,"dependency_fraction":0.02152317880794702},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GATA6","total_profiled":1310},"omim":[{"mim_id":"617912","title":"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5","url":"https://www.omim.org/entry/617912"},{"mim_id":"614475","title":"ATRIAL SEPTAL DEFECT 9; ASD9","url":"https://www.omim.org/entry/614475"},{"mim_id":"614474","title":"ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5","url":"https://www.omim.org/entry/614474"},{"mim_id":"613303","title":"AlkB HOMOLOG 5, RNA DEMETHYLASE; ALKBH5","url":"https://www.omim.org/entry/613303"},{"mim_id":"611639","title":"ZINC FINGER GATA-LIKE PROTEIN 1; ZGLP1","url":"https://www.omim.org/entry/611639"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":57.4},{"tissue":"ovary","ntpm":70.1}],"url":"https://www.proteinatlas.org/search/GATA6"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q92908","domains":[{"cath_id":"3.30.50.10","chopping":"386-434","consensus_level":"medium","plddt":87.5708,"start":386,"end":434},{"cath_id":"3.30.50.10","chopping":"436-487","consensus_level":"medium","plddt":91.7088,"start":436,"end":487}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92908","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92908-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92908-F1-predicted_aligned_error_v6.png","plddt_mean":52.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GATA6","jax_strain_url":"https://www.jax.org/strain/search?query=GATA6"},"sequence":{"accession":"Q92908","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92908.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92908/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92908"}},"corpus_meta":[{"pmid":"9832509","id":"PMC_9832509","title":"GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9832509","citation_count":534,"is_preprint":false},{"pmid":"11356841","id":"PMC_11356841","title":"The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11356841","citation_count":301,"is_preprint":false},{"pmid":"32156747","id":"PMC_32156747","title":"GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/32156747","citation_count":282,"is_preprint":false},{"pmid":"18536717","id":"PMC_18536717","title":"A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18536717","citation_count":229,"is_preprint":false},{"pmid":"27325420","id":"PMC_27325420","title":"GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer.","date":"2016","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/27325420","citation_count":219,"is_preprint":false},{"pmid":"24835466","id":"PMC_24835466","title":"GATA6 levels modulate primitive endoderm cell fate choice and timing in the mouse blastocyst.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24835466","citation_count":179,"is_preprint":false},{"pmid":"9231805","id":"PMC_9231805","title":"Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary.","date":"1997","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9231805","citation_count":179,"is_preprint":false},{"pmid":"25024137","id":"PMC_25024137","title":"Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25024137","citation_count":175,"is_preprint":false},{"pmid":"25209243","id":"PMC_25209243","title":"Gata6, Nanog and Erk signaling control cell fate in the inner cell mass through a tristable regulatory network.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25209243","citation_count":170,"is_preprint":false},{"pmid":"10067876","id":"PMC_10067876","title":"Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis.","date":"1999","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10067876","citation_count":169,"is_preprint":false},{"pmid":"16847256","id":"PMC_16847256","title":"A threshold of GATA4 and GATA6 expression is required for cardiovascular development.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16847256","citation_count":166,"is_preprint":false},{"pmid":"32041891","id":"PMC_32041891","title":"miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32041891","citation_count":147,"is_preprint":false},{"pmid":"28504705","id":"PMC_28504705","title":"Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28504705","citation_count":134,"is_preprint":false},{"pmid":"23006325","id":"PMC_23006325","title":"Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23006325","citation_count":130,"is_preprint":false},{"pmid":"23006330","id":"PMC_23006330","title":"GATA4 and GATA6 control mouse pancreas organogenesis.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23006330","citation_count":125,"is_preprint":false},{"pmid":"11959831","id":"PMC_11959831","title":"GATA6 regulates differentiation of distal lung epithelium.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11959831","citation_count":119,"is_preprint":false},{"pmid":"32402285","id":"PMC_32402285","title":"HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32402285","citation_count":113,"is_preprint":false},{"pmid":"26109048","id":"PMC_26109048","title":"Gata6 potently initiates reprograming of pluripotent and differentiated cells to extraembryonic endoderm stem cells.","date":"2015","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/26109048","citation_count":103,"is_preprint":false},{"pmid":"16887115","id":"PMC_16887115","title":"Gata6 is an important regulator of mouse pancreas development.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16887115","citation_count":96,"is_preprint":false},{"pmid":"20631719","id":"PMC_20631719","title":"A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect.","date":"2010","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20631719","citation_count":95,"is_preprint":false},{"pmid":"21839733","id":"PMC_21839733","title":"GATA5 interacts with GATA4 and GATA6 in outflow tract development.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21839733","citation_count":87,"is_preprint":false},{"pmid":"24452072","id":"PMC_24452072","title":"The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24452072","citation_count":86,"is_preprint":false},{"pmid":"25596178","id":"PMC_25596178","title":"The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.","date":"2015","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/25596178","citation_count":76,"is_preprint":false},{"pmid":"33846140","id":"PMC_33846140","title":"A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer.","date":"2021","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/33846140","citation_count":73,"is_preprint":false},{"pmid":"18816845","id":"PMC_18816845","title":"Dynamic GATA6 expression in primitive endoderm formation and maturation in early mouse embryogenesis.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18816845","citation_count":72,"is_preprint":false},{"pmid":"29567669","id":"PMC_29567669","title":"GATA6 Regulates Aortic Valve Remodeling, and Its Haploinsufficiency Leads to Right-Left Type Bicuspid Aortic Valve.","date":"2018","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/29567669","citation_count":72,"is_preprint":false},{"pmid":"15456727","id":"PMC_15456727","title":"Distinct GATA6- and laminin-dependent mechanisms regulate endodermal and ectodermal embryonic stem cell fates.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15456727","citation_count":70,"is_preprint":false},{"pmid":"32907838","id":"PMC_32907838","title":"EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32907838","citation_count":69,"is_preprint":false},{"pmid":"24929016","id":"PMC_24929016","title":"GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24929016","citation_count":62,"is_preprint":false},{"pmid":"17463088","id":"PMC_17463088","title":"GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17463088","citation_count":61,"is_preprint":false},{"pmid":"26932670","id":"PMC_26932670","title":"GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26932670","citation_count":59,"is_preprint":false},{"pmid":"19581290","id":"PMC_19581290","title":"Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19581290","citation_count":58,"is_preprint":false},{"pmid":"22672670","id":"PMC_22672670","title":"MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.","date":"2012","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22672670","citation_count":52,"is_preprint":false},{"pmid":"33082341","id":"PMC_33082341","title":"Contribution of GATA6 to homeostasis of the human upper pilosebaceous unit and acne pathogenesis.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33082341","citation_count":51,"is_preprint":false},{"pmid":"33054971","id":"PMC_33054971","title":"GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33054971","citation_count":48,"is_preprint":false},{"pmid":"33859766","id":"PMC_33859766","title":"HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the GATA6 promoter.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33859766","citation_count":47,"is_preprint":false},{"pmid":"37914087","id":"PMC_37914087","title":"The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair.","date":"2023","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/37914087","citation_count":46,"is_preprint":false},{"pmid":"33915173","id":"PMC_33915173","title":"TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33915173","citation_count":44,"is_preprint":false},{"pmid":"30629940","id":"PMC_30629940","title":"GATA6 Cooperates with EOMES/SMAD2/3 to Deploy the Gene Regulatory Network Governing Human Definitive Endoderm and Pancreas Formation.","date":"2019","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30629940","citation_count":43,"is_preprint":false},{"pmid":"24415953","id":"PMC_24415953","title":"GATA6 is a crucial regulator of Shh in the limb bud.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24415953","citation_count":42,"is_preprint":false},{"pmid":"29653232","id":"PMC_29653232","title":"GATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29653232","citation_count":42,"is_preprint":false},{"pmid":"36623953","id":"PMC_36623953","title":"Gata6+ large peritoneal macrophages: an evolutionarily conserved sentinel and effector system for infection and injury.","date":"2023","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36623953","citation_count":41,"is_preprint":false},{"pmid":"26387746","id":"PMC_26387746","title":"REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26387746","citation_count":41,"is_preprint":false},{"pmid":"35871075","id":"PMC_35871075","title":"Extensive co-binding and rapid redistribution of NANOG and GATA6 during emergence of divergent lineages.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35871075","citation_count":40,"is_preprint":false},{"pmid":"33876316","id":"PMC_33876316","title":"Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis.","date":"2021","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/33876316","citation_count":40,"is_preprint":false},{"pmid":"33060563","id":"PMC_33060563","title":"GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33060563","citation_count":39,"is_preprint":false},{"pmid":"22750565","id":"PMC_22750565","title":"GATA6 loss-of-function mutation in atrial fibrillation.","date":"2012","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22750565","citation_count":38,"is_preprint":false},{"pmid":"27908934","id":"PMC_27908934","title":"Gata6 promotes hair follicle progenitor cell renewal by genome maintenance during proliferation.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27908934","citation_count":37,"is_preprint":false},{"pmid":"34294813","id":"PMC_34294813","title":"The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34294813","citation_count":37,"is_preprint":false},{"pmid":"29928408","id":"PMC_29928408","title":"miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29928408","citation_count":35,"is_preprint":false},{"pmid":"35906202","id":"PMC_35906202","title":"Gata6+ resident peritoneal macrophages promote the growth of liver metastasis.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35906202","citation_count":35,"is_preprint":false},{"pmid":"35536676","id":"PMC_35536676","title":"A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35536676","citation_count":34,"is_preprint":false},{"pmid":"23583651","id":"PMC_23583651","title":"Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23583651","citation_count":34,"is_preprint":false},{"pmid":"17337116","id":"PMC_17337116","title":"Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17337116","citation_count":33,"is_preprint":false},{"pmid":"31322171","id":"PMC_31322171","title":"The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.","date":"2019","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31322171","citation_count":33,"is_preprint":false},{"pmid":"30194255","id":"PMC_30194255","title":"Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.","date":"2018","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30194255","citation_count":33,"is_preprint":false},{"pmid":"36109153","id":"PMC_36109153","title":"GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.","date":"2022","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/36109153","citation_count":32,"is_preprint":false},{"pmid":"33318580","id":"PMC_33318580","title":"Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma.","date":"2020","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/33318580","citation_count":32,"is_preprint":false},{"pmid":"29402198","id":"PMC_29402198","title":"The Essential Role of GATA6 in the Activation of Estrogen Synthesis in Endometriosis.","date":"2018","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/29402198","citation_count":32,"is_preprint":false},{"pmid":"32795420","id":"PMC_32795420","title":"GATA6-AS1 Regulates GATA6 Expression to Modulate Human Endoderm Differentiation.","date":"2020","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32795420","citation_count":31,"is_preprint":false},{"pmid":"33252174","id":"PMC_33252174","title":"GATA6 regulates aging of human mesenchymal stem/stromal cells.","date":"2020","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/33252174","citation_count":31,"is_preprint":false},{"pmid":"30674866","id":"PMC_30674866","title":"GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30674866","citation_count":31,"is_preprint":false},{"pmid":"29106391","id":"PMC_29106391","title":"Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29106391","citation_count":30,"is_preprint":false},{"pmid":"37339559","id":"PMC_37339559","title":"Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37339559","citation_count":29,"is_preprint":false},{"pmid":"31437305","id":"PMC_31437305","title":"Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers.","date":"2019","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31437305","citation_count":28,"is_preprint":false},{"pmid":"28615712","id":"PMC_28615712","title":"Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28615712","citation_count":28,"is_preprint":false},{"pmid":"34374415","id":"PMC_34374415","title":"GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation.","date":"2022","source":"Journal of Crohn's & colitis","url":"https://pubmed.ncbi.nlm.nih.gov/34374415","citation_count":27,"is_preprint":false},{"pmid":"29454706","id":"PMC_29454706","title":"GATA6 phosphorylation by Erk1/2 propels exit from pluripotency and commitment to primitive endoderm.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29454706","citation_count":27,"is_preprint":false},{"pmid":"22607194","id":"PMC_22607194","title":"GATA6 and FOXA2 regulate Wnt6 expression during extraembryonic endoderm formation.","date":"2012","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/22607194","citation_count":26,"is_preprint":false},{"pmid":"11429286","id":"PMC_11429286","title":"Branching and differentiation defects in pulmonary epithelium with elevated Gata6 expression.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11429286","citation_count":26,"is_preprint":false},{"pmid":"36655602","id":"PMC_36655602","title":"GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis.","date":"2023","source":"Journal of Crohn's & colitis","url":"https://pubmed.ncbi.nlm.nih.gov/36655602","citation_count":25,"is_preprint":false},{"pmid":"24970044","id":"PMC_24970044","title":"Developmental lung expression and transcriptional regulation of claudin-6 by TTF-1, Gata-6, and FoxA2.","date":"2014","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/24970044","citation_count":25,"is_preprint":false},{"pmid":"32103545","id":"PMC_32103545","title":"Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32103545","citation_count":24,"is_preprint":false},{"pmid":"25933105","id":"PMC_25933105","title":"Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors.","date":"2015","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25933105","citation_count":24,"is_preprint":false},{"pmid":"34858502","id":"PMC_34858502","title":"lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability.","date":"2021","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/34858502","citation_count":24,"is_preprint":false},{"pmid":"30886049","id":"PMC_30886049","title":"Mutant Lef1 controls Gata6 in sebaceous gland development and cancer.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30886049","citation_count":23,"is_preprint":false},{"pmid":"31809214","id":"PMC_31809214","title":"LncRNA GATA6-AS Promotes Cancer Cell Proliferation and Inhibits Apoptosis in Glioma by Downregulating lncRNA TUG1.","date":"2019","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/31809214","citation_count":23,"is_preprint":false},{"pmid":"37647897","id":"PMC_37647897","title":"Control of murine brown adipocyte development by GATA6.","date":"2023","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/37647897","citation_count":22,"is_preprint":false},{"pmid":"29263149","id":"PMC_29263149","title":"GATA6 Controls Insulin Biosynthesis and Secretion in Adult β-Cells.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29263149","citation_count":22,"is_preprint":false},{"pmid":"33443158","id":"PMC_33443158","title":"GATA6 is a regulator of sinus node development and heart rhythm.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33443158","citation_count":22,"is_preprint":false},{"pmid":"28270130","id":"PMC_28270130","title":"miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis.","date":"2017","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28270130","citation_count":22,"is_preprint":false},{"pmid":"18303859","id":"PMC_18303859","title":"Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factors.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18303859","citation_count":22,"is_preprint":false},{"pmid":"16150495","id":"PMC_16150495","title":"Expression of GATA6 in the human and mouse central nervous system.","date":"2005","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16150495","citation_count":22,"is_preprint":false},{"pmid":"36113831","id":"PMC_36113831","title":"IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.","date":"2022","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36113831","citation_count":22,"is_preprint":false},{"pmid":"31120883","id":"PMC_31120883","title":"Gata4 regulates hedgehog signaling and Gata6 expression for outflow tract development.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31120883","citation_count":21,"is_preprint":false},{"pmid":"36788090","id":"PMC_36788090","title":"GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy.","date":"2023","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/36788090","citation_count":21,"is_preprint":false},{"pmid":"27756709","id":"PMC_27756709","title":"Gain-of-function mutations in GATA6 lead to atrial fibrillation.","date":"2016","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/27756709","citation_count":21,"is_preprint":false},{"pmid":"37059928","id":"PMC_37059928","title":"GATA6 Inhibits Neuronal Autophagy and Ferroptosis in Cerebral ischemia-reperfusion Injury Through a miR-193b/ATG7 axis-dependent Mechanism.","date":"2023","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/37059928","citation_count":20,"is_preprint":false},{"pmid":"23275439","id":"PMC_23275439","title":"GATA-6 and NF-κB activate CPI-17 gene transcription and regulate Ca2+ sensitization of smooth muscle contraction.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23275439","citation_count":20,"is_preprint":false},{"pmid":"30834518","id":"PMC_30834518","title":"Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30834518","citation_count":18,"is_preprint":false},{"pmid":"31092103","id":"PMC_31092103","title":"GATA6-upregulating autophagy promotes TKI resistance in nonsmall cell lung cancer.","date":"2019","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31092103","citation_count":18,"is_preprint":false},{"pmid":"32888237","id":"PMC_32888237","title":"A long non-coding RNA GATA6-AS1 adjacent to GATA6 is required for cardiomyocyte differentiation from human pluripotent stem cells.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32888237","citation_count":18,"is_preprint":false},{"pmid":"30589192","id":"PMC_30589192","title":"GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions.","date":"2019","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/30589192","citation_count":17,"is_preprint":false},{"pmid":"38733987","id":"PMC_38733987","title":"GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery.","date":"2024","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38733987","citation_count":17,"is_preprint":false},{"pmid":"30033638","id":"PMC_30033638","title":"Loss of Gata6 causes dilation of the hair follicle canal and sebaceous duct.","date":"2018","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30033638","citation_count":16,"is_preprint":false},{"pmid":"18191120","id":"PMC_18191120","title":"A role for GATA-6 in vertebrate chondrogenesis.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18191120","citation_count":16,"is_preprint":false},{"pmid":"37735598","id":"PMC_37735598","title":"Myc-dependent dedifferentiation of Gata6+ epidermal cells resembles reversal of terminal differentiation.","date":"2023","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37735598","citation_count":15,"is_preprint":false},{"pmid":"27511375","id":"PMC_27511375","title":"Elevated expression of steroidogenesis pathway genes; CYP17, GATA6 and StAR in prenatally androgenized rats.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27511375","citation_count":15,"is_preprint":false},{"pmid":"24887481","id":"PMC_24887481","title":"Activated protease receptor-2 induces GATA6 expression to promote survival in irradiated colon cancer cells.","date":"2014","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/24887481","citation_count":15,"is_preprint":false},{"pmid":"29889101","id":"PMC_29889101","title":"GATA6 suppression enhances lung specification from human pluripotent stem cells.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29889101","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51776,"output_tokens":12563,"usd":0.171886,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23895,"output_tokens":9728,"usd":0.181338,"stage2_stop_reason":"end_turn"},"total_usd":0.353224,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GATA6 lies upstream of HNF4 in a transcriptional cascade regulating visceral endoderm differentiation; GATA6-null mice lack HNF4 expression in the endoderm, and forced GATA6 expression activates the HNF4 promoter in non-endodermal cells. GATA6-null embryoid bodies fail to form a visceral endoderm layer and lack expression of GATA4, AFP, and HNF3beta.\",\n      \"method\": \"Gene targeting (GATA6-null ES cells and mice), embryoid body differentiation, promoter activation assay, chimeric mouse analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genetic loss-of-function with multiple downstream markers, promoter activation assay, and chimeric rescue experiments in a landmark study\",\n      \"pmids\": [\"9832509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Overexpression of GATA6 in cardiomyocytes is sufficient to induce hypertrophic growth (increased cell surface area, sarcomeric organization, protein accumulation), and a dominant-negative GATA4-engrailed repressor blocks GATA6-directed transcriptional responses and agonist-induced hypertrophy, demonstrating that GATA6 is a necessary mediator of cardiomyocyte hypertrophy.\",\n      \"method\": \"Recombinant adenovirus overexpression in cardiomyocytes, dominant-negative fusion protein (GATA4-engrailed), transgenic mouse overexpression, cell surface area and protein accumulation measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function and dominant-negative loss-of-function in vitro and in vivo with multiple orthogonal phenotypic readouts\",\n      \"pmids\": [\"11356841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GATA6 is required for differentiation of alveolar epithelial type 1 cells in the distal lung; dominant-negative GATA6-Engrailed expression abolishes type 1 cells, increases Foxp2, and attenuates surfactant protein C expression. GATA6 can trans-activate the aquaporin-5 promoter, indicating direct transcriptional control of AT1-specific genes.\",\n      \"method\": \"Dominant-negative transgenic mice (GATA6-Engrailed driven by SP-C promoter), promoter trans-activation assay\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative in vivo with specific cellular phenotype plus direct promoter activation assay\",\n      \"pmids\": [\"11959831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Endoderm differentiation and endoderm-specific gene expression (including laminin 1 subunits) in embryoid bodies is controlled by FGF-induced GATA6; GATA6-transformed Lamc1-null endoderm-like cells show that laminin 1 in the basement membrane subsequently induces epiblast differentiation.\",\n      \"method\": \"GATA6 overexpression in ES cells, embryoid body differentiation, pharmacological inhibitors (dominant-negative), gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression and genetic manipulations with defined downstream markers, single lab\",\n      \"pmids\": [\"15456727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Gata6, but not Gata4, physically interacts with Nkx2.2 (an essential islet transcription factor). Dominant-negative Gata6-Engrailed expression in the pancreatic epithelium causes pancreatic agenesis or severe reduction of all pancreatic cell types, demonstrating Gata6 is an important regulator of pancreas specification.\",\n      \"method\": \"Co-immunoprecipitation (physical interaction with Nkx2.2), dominant-negative Gata6-Engrailed transgenic mice, histological analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP for binding plus in vivo dominant-negative with cellular phenotype, single lab\",\n      \"pmids\": [\"16887115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Compound heterozygosity for GATA4 and GATA6 null alleles causes embryonic lethality with cardiovascular defects (thin-walled myocardium, septal defects), reduced cardiomyocyte proliferation, and downregulation of MEF2C and beta-myosin heavy chain, revealing a dosage threshold for GATA4/GATA6 activity in cardiovascular gene expression.\",\n      \"method\": \"Compound heterozygous mouse genetics, histology, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with precise dosage effect, multiple cardiovascular phenotypic readouts, mechanistic downstream targets identified\",\n      \"pmids\": [\"16847256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Gata6 regulates the temporal appearance and number of bronchioalveolar stem cells (BASCs) by suppressing canonical Wnt signaling; loss of Gata6 increases canonical Wnt signaling and causes precocious BASC expansion. Gata6 regulates expression of the non-canonical Wnt receptor Fzd2, and increased Fzd2 or decreased beta-catenin rescues lung epithelial defects in Gata6 mutants.\",\n      \"method\": \"Conditional Gata6-null lung epithelium mice, genetic rescue (Fzd2 expression, beta-catenin reduction), Wnt signaling reporter assays, postnatal Gata6 deletion\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with genetic rescue experiments, multiple orthogonal methods establishing pathway position\",\n      \"pmids\": [\"18536717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dynamic GATA6 expression distinguishes parietal endoderm (GATA6+) from visceral endoderm (GATA6 lost by E5.5). GATA6-null embryos fail to form a morphologically recognizable primitive endoderm layer, establishing GATA6 as essential for primitive endoderm formation at an earlier stage than previously recognized.\",\n      \"method\": \"Immunofluorescence, in situ hybridization, GATA6-null mouse embryo analysis\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — null mouse phenotype with temporal expression analysis; single lab\",\n      \"pmids\": [\"18816845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GATA6 and FOXA2 directly bind to the Wnt6 promoter and activate its transcription, linking GATA6 to canonical WNT-β-catenin pathway activation during primitive endoderm formation in F9 teratocarcinoma cells.\",\n      \"method\": \"Chromatin immunoprecipitation, luciferase reporter assay, overexpression of Gata6 and Foxa2 in F9 cells\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assays confirming direct binding and transcriptional activation; single lab\",\n      \"pmids\": [\"22607194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GATA6 activates calreticulin gene transcription by binding to site 1 on the calreticulin promoter (shown by EMSA and ChIP), while Evi-1 represses calreticulin and antagonizes GATA6-mediated activation at the same site.\",\n      \"method\": \"EMSA, chromatin immunoprecipitation, site-specific mutagenesis, reporter assays in neonatal cardiomyocytes and fibroblasts\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding shown by EMSA and ChIP with mutagenesis; single lab\",\n      \"pmids\": [\"18303859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"siRNA-mediated reduction of GATA6 in human ovarian surface epithelial cells causes nuclear envelope deformation, failure of cytokinesis, and formation of polyploid/aneuploid cells. Loss of the nuclear envelope protein emerin mediates these consequences; direct siRNA suppression of emerin phenocopies GATA6 loss.\",\n      \"method\": \"siRNA knockdown, flow cytometry, immunofluorescence, nuclear morphology analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with mechanistic epistasis (emerin), single lab\",\n      \"pmids\": [\"19581290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Simultaneous pancreas-specific deletion of both Gata4 and Gata6 causes severe pancreatic agenesis due to failure of progenitor cell proliferation, defects in branching morphogenesis, and loss of CPA1+ and NEUROG3+ progenitor differentiation; single deletion of either factor yields only mild defects that resolve postnatally.\",\n      \"method\": \"Conditional double knockout mice (Pdx1-Cre; Gata4fl/fl; Gata6fl/fl), histology, immunostaining, gene expression\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated independently in two simultaneous publications with conditional genetics and multiple cellular phenotype readouts\",\n      \"pmids\": [\"23006325\", \"23006330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Endothelial GATA-6 directly transcriptionally regulates genes controlling vascular tone (endothelin-1, eNOS) and pro-inflammatory genes (CX3CL1, PAI-1, RhoB). Endothelial-specific Gata6 knockout mice spontaneously develop elevated pulmonary artery pressure and increased vessel muscularization, with innate immune cell infiltration.\",\n      \"method\": \"Endothelial-specific Gata6 conditional KO mice, pulmonary artery pressure measurement, histology, gene expression analysis\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-specific KO with direct target gene regulation and in vivo vascular phenotype; single lab\",\n      \"pmids\": [\"23583651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GATA6 levels regulate timing and speed of primitive endoderm (PrE) lineage commitment in the inner cell mass; GATA6 is necessary for PrE specification by FGF signaling; quantitative single-cell imaging shows that absence of GATA6 completely abolishes PrE and that GATA6 levels interact with NANOG and FGF/ERK to determine ICM fate.\",\n      \"method\": \"Quantitative single-cell-resolution image analysis, GATA6 hypomorphic and null embryos, FGF/ERK pathway manipulation\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative imaging plus genetic dosage series with FGF pathway epistasis, multiple labs converging on same model\",\n      \"pmids\": [\"24835466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In mouse ICM, absence of GATA6 causes all cells to adopt epiblast identity, while absence of NANOG causes all cells to adopt PrE identity; these findings support a tristable regulatory network model where ERK signaling and concentrations of Nanog, Gata6, Fgf4, and Fgfr2 control ICM cell fate.\",\n      \"method\": \"Gata6-null and Gata6+/- embryo analysis, mathematical modeling, FGF/Erk pathway manipulation\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with mathematical modeling, single lab with supporting modeling\",\n      \"pmids\": [\"25209243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GATA6 directly enhances LGR5 expression, and miR-363 downregulates GATA6 thereby suppressing LGR5 and colorectal cancer tumourigenicity. The miR-363-GATA6-LGR5 axis is required for colorectal cancer tumorigenicity.\",\n      \"method\": \"Overexpression/knockdown assays, luciferase reporter assay (miR-363 targeting GATA6 3'UTR), in vivo xenograft\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay validating direct targeting, in vivo xenograft, single lab\",\n      \"pmids\": [\"24452072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GATA6 and GATA4 maintain pancreatic endoderm identity in part by repressing hedgehog signaling; in Gata4/Gata6 double-knockout pancreatic progenitors, hedgehog pathway components are ectopically upregulated, and GATA4/GATA6 can repress transcription through the Shh endoderm-specific enhancer MACS1, requiring GATA-binding sites within this enhancer.\",\n      \"method\": \"Double conditional KO mice (pDKO), reporter assay with MACS1 enhancer, GATA binding site mutagenesis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with enhancer mutagenesis reporter assay; single lab\",\n      \"pmids\": [\"26932670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GATA6 is a crucial regulator of Shh expression in the hindlimb bud; conditional Gata6 deletion from developing limbs causes ectopic Shh expression and preaxial polydactyly, and forced GATA6 expression represses Shh. GATA6 binds to regulatory elements of Shh and Gli1 in limb bud chromatin and represses their expression synergistically with FOG co-factors. Loss of Shh in Gata6-null limbs prevents polydactyly, placing GATA6 upstream of Shh.\",\n      \"method\": \"Conditional Gata6 KO (Prx1-Cre), forced Gata6 expression, ChIP, luciferase reporter assay, genetic epistasis (Shh/Gata6 double conditional KO)\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO, genetic epistasis (compound mutant rescue), ChIP, and reporter assay with mutagenesis in one study\",\n      \"pmids\": [\"24415953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gata6 is sufficient to initiate reprogramming of multiple cell types (pluripotent and differentiated neural cells) to induced extraembryonic endoderm stem cells. ChIP-seq shows GATA6 enrichment near both pluripotency and endoderm genes, functioning as a direct repressor of pluripotency genes (Nanog, Esrrb, Sox2, Oct4) and activator of ExEn genes in a stepwise manner.\",\n      \"method\": \"Inducible Gata6 expression, cell reprogramming assays, ChIP-seq, transcriptional profiling\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus transcriptional profiling plus functional reprogramming across multiple cell types; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"26109048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gata6 maintains acinar differentiation and suppresses KrasG12V-driven pancreatic tumorigenesis; ChIP-seq and RNA-seq show that GATA6 directly represses the EGFR pathway and inflammatory pathways in the pancreas; Gata6 ablation renders acinar cells more sensitive to KRas(G12V) and accelerates tumor development.\",\n      \"method\": \"Genetically engineered mouse models, ChIP-seq, RNA-seq, GATA6 silencing in human PDAC cells\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic model plus ChIP-seq and RNA-seq identifying direct target pathways; single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"25596178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GATA6 inhibits epithelial-mesenchymal transition (EMT) in pancreatic cancer cells in vitro and cell dissemination in vivo; GATA6 ChIP-seq and RNA-seq demonstrate direct transcriptional regulation of EMT-related genes and indirect regulation through other EMT transcription factors.\",\n      \"method\": \"GATA6 silencing and overexpression in PDAC cell lines, ChIP-seq, RNA-seq, in vivo dissemination assay\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function plus genome-wide ChIP-seq and RNA-seq in primary patient samples; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27325420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Gata6 controls the renewal of rapidly proliferating hair follicle matrix progenitor cells by protecting against DNA damage associated with proliferation; Gata6 stimulates Edaradd expression and NF-κB pathway activation, and Edaradd rescues DNA damage, cell survival, proliferation, and MCM10 expression in Gata6-null keratinocytes.\",\n      \"method\": \"Conditional Gata6 KO mice, cultured keratinocyte rescue experiments with Edaradd, DNA damage assays, gene expression analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in vivo with mechanistic rescue (Edaradd), single lab\",\n      \"pmids\": [\"27908934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Gata6 controls the identity of the sebaceous duct lineage and specifies a lineage switch between sebocytes and SD cells; during wound healing, differentiated Gata6+ cells migrate from the sebaceous duct into the interfollicular epidermis and dedifferentiate, acquiring long-term self-renewal ability and multilineage differentiation capacity.\",\n      \"method\": \"Conditional Gata6 KO mice, lineage tracing, live imaging, clonogenic assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with lineage tracing and functional self-renewal assays; published in high-impact journal with multiple methods\",\n      \"pmids\": [\"28504705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GATA6 is required for normal insulin biosynthesis and secretion in adult β-cells; pancreas-specific Gata6 inactivation causes glucose intolerance, decreased insulin content, impaired insulin secretion, and ultrastructural abnormalities in β-cells. Pdx1 expression in adult β-cells depends on GATA-binding sites, and GATA6 loss greatly affects β-cell-specific gene expression.\",\n      \"method\": \"Pancreas-specific Gata6 KO mice, glucose tolerance testing, insulin secretion assays, electron microscopy, transgenic reporter mice with GATA site mutations\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with functional metabolic readouts, ultrastructural analysis, and reporter assay with GATA site mutation; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29263149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GATA6 and Sp1 interact and cooperatively activate Aqp5 transcription via histone H3 acetylation; GATA6 competes with HDAC3 for Sp1 binding, and p300 modulates H3 acetylation through interactions with GATA6/Sp1. GATA6 knockdown decreases AQP5 expression in alveolar epithelial cells.\",\n      \"method\": \"siRNA knockdown, HDAC inhibitor treatment, Co-IP (GATA6/Sp1/p300/HDAC3 interactions), ChIP for histone acetylation, reporter assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, and reporter assays with knockdown; single lab with multiple biochemical methods\",\n      \"pmids\": [\"28615712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Phosphorylation of GATA6 at a conserved serine residue (S264) by Erk1/2 is required for GATA6 to activate its own promoter and drive a positive feedback loop for primitive endoderm differentiation; S264 mutations drastically impair GATA6's ability to activate its own promoter in ES cells.\",\n      \"method\": \"Gata6-H2BGFP knock-in mouse, ES cell differentiation, site-directed mutagenesis of S264, promoter activation assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of specific phosphorylation site with functional promoter assay and in vivo reporter mouse; single lab with mechanistic precision\",\n      \"pmids\": [\"29454706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Gata6 haploinsufficiency causes highly penetrant right-left-type bicuspid aortic valve in mice. Mechanistically, Gata6 haploinsufficiency disrupts valve remodeling and extracellular matrix composition through dysregulation of MMP9. Cell-specific inactivation reveals that GATA6 is required specifically in secondary heart field (Isl-1-positive) myocytes, not endothelial or neural crest cells, for aortic valve formation.\",\n      \"method\": \"Gata6 heterozygous mice, cell-specific conditional KO (Isl-1-Cre, endothelial-Cre, neural crest-Cre), MMP9 expression analysis, human GWAS validation\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cell-specific conditional KOs establishing precise cellular requirement, mechanistic target (MMP9), and human genetic validation\",\n      \"pmids\": [\"29567669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In endometriosis, GATA6 is necessary for CYP17A1-mediated conversion of progesterone to androstenedione in endometriotic cells, and simultaneous expression of both GATA6 and NR5A1 is required and sufficient to activate all five steroidogenic genes (HSD3B2, CYP17A1, CYP19A1 and others) and estradiol production in normal endometrial stromal cells.\",\n      \"method\": \"Ectopic expression and siRNA knockdown of GATA6 and NR5A1 in endometrial and endometriotic stromal cells, estradiol ELISA, RT-qPCR, western blot\",\n      \"journal\": \"Reproductive sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with functional estradiol output assay; single lab\",\n      \"pmids\": [\"29402198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GATA6 cooperates with EOMES/SMAD2/3 to regulate cardinal endoderm gene expression at the genome-wide level; GATA6-null human PSCs fail to enter the definitive endoderm lineage, while heterozygous cells show modest DE reduction, explaining the human-specific pancreatic agenesis with heterozygous GATA6 mutations.\",\n      \"method\": \"Gene-edited and patient-derived hPSCs, directed differentiation, ChIP-seq (GATA6, EOMES, SMAD2/3), RNA-seq, flow cytometry\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq for three factors, isogenic GATA6-null and heterozygous hPSCs with directed differentiation, multiple orthogonal methods\",\n      \"pmids\": [\"30629940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GATA6 directly upregulates CD137L (TNFSF9) expression in cutaneous T-cell lymphoma cells by binding to its promoter; GATA6 overexpression in CTCL is driven by DNA hypomethylation and histone acetylation, and GATA6 inhibition decreases CTCL cell survival and in vivo growth.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, shRNA knockdown, flow cytometry, in vivo mouse xenograft\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with functional knockdown in vivo; single lab\",\n      \"pmids\": [\"30194255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GATA6 directly transcribes miR-520b (shown by luciferase reporter and ChIP assays), and miR-520b suppresses CREB1, establishing a GATA6/miR-520b/CREB1 axis that suppresses gastric cancer cell migration and metastasis.\",\n      \"method\": \"Luciferase reporter assay, ChIP, overexpression/knockdown, in vivo metastasis model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay confirming direct binding with in vivo functional validation; single lab\",\n      \"pmids\": [\"30674866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GATA6 directly binds the promoter of the PKM gene and regulates PKM2 transcription; GATA6 silencing in HCC cells promotes glycolytic metabolism, EMT, tumorigenicity, and self-renewal via PKM2 upregulation.\",\n      \"method\": \"ChIP assay, gene knockdown and overexpression, metabolic assays (glucose uptake), in vivo tumorigenicity\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter binding, functional metabolic and tumorigenic phenotype; single lab\",\n      \"pmids\": [\"30834518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GATA6 physically interacts with LOXL2 (the scavenger receptor cysteine-rich domain of LOXL2 interacts with GATA6), and this complex promotes VEGFA mRNA expression and protein secretion, driving angiogenesis and tube formation in cholangiocarcinoma.\",\n      \"method\": \"Co-immunoprecipitation, western blot, RT-qPCR, ELISA, tube formation assay, in vivo xenograft\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP for physical interaction plus functional angiogenesis assays; single lab\",\n      \"pmids\": [\"31322171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Gata4 directly represses Gata6 transcription through responsive repressive sites within 1 kb upstream of the Gata6 transcription start site, shown by ChIP-qPCR and luciferase reporter assay; enhanced Gata6 expression in Gata4 heterozygous SHF cells contributes to outflow tract defects.\",\n      \"method\": \"ChIP-qPCR, luciferase reporter assay, Gata4 heterozygous mouse model, gene expression analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with mutagenesis plus in vivo genetic model; single lab\",\n      \"pmids\": [\"31120883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GATA6 is a pioneer factor in cardiac development: it regulates SMYD1 (which activates HAND2) and KDR (which with HAND2 orchestrates outflow tract formation). GATA6 loss-of-function variants perturb cardiac and endoderm lineage genes directing PDX1/pancreatic development. An exon 4 GATA6 missense variant causes ectopic pioneer activities, reducing GATA4, FOXA1/2, and PDX1 and increasing retinoic acid signaling promoting diaphragm development.\",\n      \"method\": \"Isogenic iPSC cardiomyocyte differentiation, RNA-seq, ATAC-seq (chromatin accessibility), ChIP-seq, GATA6 LoF and missense variant comparison\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isogenic iPSC system with GATA6 LoF and missense variants, genome-wide ATAC-seq and RNA-seq, multiple mechanistic targets identified; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33054971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EZH2 transcriptionally represses GATA6 in PDAC via H3K27 methylation; genetic or pharmacologic EZH2 depletion increases GATA6 expression and induces a classical gene signature, while GATA6 re-ablation in EZH2-deficient cells rescues invasive capacity and basal gene signature.\",\n      \"method\": \"ChIP-seq (EZH2 on GATA6 locus), RNA-seq, GATA6 knockdown in EZH2-depleted cells, transgenic PDAC models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus RNA-seq plus epistatic rescue experiment establishing direct epigenetic repression; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32907838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GATA6 directly binds the promoter of VEGF-C at its promoter region and acts as a transcriptional repressor; loss of GATA6 in bladder cancer (via promoter hypermethylation) leads to VEGF-C upregulation, promoting lymphangiogenesis and lymph node metastasis.\",\n      \"method\": \"ChIP assay, promoter binding assay, GATA6 reconstitution and knockdown, in vivo lymph node metastasis model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct promoter binding with functional in vivo metastasis readout; single lab\",\n      \"pmids\": [\"32103545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GATA6 directly upregulates MUC1 expression by binding to GATA-motifs at positions -1584 and -1456 in the MUC1 promoter; MUC1 then binds to β-catenin and increases nuclear β-catenin levels, driving EMT and metastasis in cholangiocarcinoma.\",\n      \"method\": \"ChIP-seq, luciferase reporter assay with point-mutant GATA sites, co-immunoprecipitation (MUC1/β-catenin), knockdown/overexpression, in vivo metastasis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus reporter mutagenesis plus Co-IP for complex; single lab\",\n      \"pmids\": [\"33060563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GATA6 controls insulin biosynthesis/secretion in adult β-cells and lung specification from human PSCs: knockdown of GATA6 during endoderm patterning increases NKX2.1+ lung progenitors, while GATA6 ablation impairs terminal lung differentiation; transgenic GATA6 expression skews development toward liver fate at the expense of lung progenitors, revealing a dosage effect.\",\n      \"method\": \"GATA6 knockdown and null hPSC lines, directed differentiation to lung progenitors, flow cytometry, gene expression analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GATA6 null and knockdown hPSC differentiation with functional lung progenitor output; single lab\",\n      \"pmids\": [\"29889101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TET2 marks the GATA6 locus with 5-hydroxymethylcytosine (5hmc) to maintain classical PDAC phenotype; SMAD4 directly supports TET2 levels, and loss of SMAD4 reduces 5hmc, GATA6 expression, and promotes squamous-like tumors. Restoring TET2 stability with metformin/vitamin C restores 5hmc and GATA6 levels and reverts squamous-like phenotype in vitro and in vivo.\",\n      \"method\": \"Oxidative bisulfite sequencing (genome-wide 5hmc and 5mc mapping), in vivo pharmacological rescue, bioinformatics iCluster\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide epigenetic mapping with in vivo pharmacological rescue; single lab\",\n      \"pmids\": [\"33915173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HDAC1/2 suppress GATA6 expression by promoting STAT3 acetylation, which enhances DNMT1 binding to STAT3 and leads to hypermethylation of the GATA6 promoter CpG region (+140/+255); blocking STAT3 acetylation at Lys685 disrupts DNMT1-STAT3 interaction and reverses GATA6 promoter methylation, demonstrating an epigenetic regulatory mechanism for GATA6 in endothelial cells.\",\n      \"method\": \"Romidepsin treatment, HDAC1/2 siRNA, methylation-specific PCR, ChIP (STAT3 enrichment at GATA6 promoter), STAT3 Lys685Arg mutation, Co-IP (DNMT1-STAT3), in vivo atherosclerosis model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, Co-IP, and mutagenesis with in vivo validation; single lab with multiple biochemical methods\",\n      \"pmids\": [\"33859766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A GATA6-centered gene regulatory network involving HNF1A and HNF4A controls PDAC subtype identity; GATA6 loss alone is necessary but not sufficient for basal program expression—concomitant loss of HNF1A and HNF4A (through epigenetic silencing) is required for the full phenotype switch. In mice, late Gata6 deletion dramatically increased metastatic rate.\",\n      \"method\": \"Dual-recombinase mouse model (Gata6LateKO), RNA-seq of primary tumor cells, human transcriptomics datasets, tissue samples\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — novel mouse model for late-stage Gata6 deletion plus RNA-seq plus human-to-mouse validation; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33846140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GATA6 directly activates TBX3 and EDN1 as key regulators of the sinus node genetic program (in conduction and non-conduction cells, respectively); Gata6 haploinsufficiency causes hypoplastic sinus node and rhythm abnormalities, and cell-specific deletion reveals requirements in multiple SAN lineages.\",\n      \"method\": \"Gata6 heterozygous and cell-specific conditional KO mice, ECG recording, histology, chromatin binding and transcriptional activation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — haploinsufficiency and cell-specific KO with direct target activation (TBX3, EDN1) and in vivo electrophysiology; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33443158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GATA6 and NANOG co-bind at the vast majority of epiblast and PrE enhancers both in embryonic stem cells and in blastocysts; upon GATA6 induction, co-binding is followed by eviction of Epi TFs, rapid chromatin remodeling and remodeling of enhancer-promoter contacts to establish PrE lineage while repressing Epi fate.\",\n      \"method\": \"Inducible GATA6 in ES cells, ChIP-seq (GATA6 and NANOG), ATAC-seq, Hi-C/4C (enhancer-promoter contacts), blastocyst ChIP\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq, chromatin accessibility, and 3D chromatin contacts in both ES cells and embryos; single lab with multiple orthogonal genome-wide methods\",\n      \"pmids\": [\"35871075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EP300 (p300) histone acetyltransferase directly supports GATA6 expression; loss of EP300 downregulates GATA6 and silences the GATA6-regulated differentiation program, causing a phenotypic switch from classical to basal-like/squamous PDAC subtype and resistance to PORCN (Wnt) inhibitors.\",\n      \"method\": \"In vivo CRISPR screen, EP300 knockdown/KO, GATA6 overexpression rescue, RNA-seq, chromatin accessibility mapping\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo CRISPR screen identifying EP300, epistatic rescue with GATA6 re-expression, RNA-seq; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"35536676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Endothelial Gata6 deletion reduces atherosclerosis by decreasing monocyte infiltration and pro-inflammatory macrophage formation; Cmpk2 and Ccl5 are identified as direct target genes of GATA6 in endothelial cells mediating these effects through the CMPK2-Nlrp3 pathway.\",\n      \"method\": \"EC-specific Gata6 KO in ApoeKO mice, endothelial AAV9-Cmpk2-shRNA delivery, ChIP (direct target identification), monocyte adhesion and migration assays, lesion quantification\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-specific KO with ChIP for direct targets and epistatic in vivo rescue; single lab\",\n      \"pmids\": [\"37339559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gata6 deletion from the brown fat lineage causes a striking loss of brown adipose tissue, identifying GATA6 as a crucial regulator of brown adipocyte development; GATA6 marks brown adipogenic progenitor cells.\",\n      \"method\": \"Single-cell gene expression analysis, immunostaining, lineage tracing, conditional Gata6 KO in brown fat lineage\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with lineage tracing and single-cell RNA-seq; single lab\",\n      \"pmids\": [\"37647897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SIRT6 inhibits GATA6 transcription by deacetylating and increasing degradation of the transcription factor Nkx2.5 (which would otherwise activate GATA6); GATA6 in turn impedes ATM-mediated DNA damage repair, leading to accelerated VSMC senescence and osteogenic differentiation. Gata6 knockdown (via AAV-shRNA) inhibits arterial calcification in CKD mice.\",\n      \"method\": \"SIRT6-transgenic mice, Gata6 AAV-shRNA knockdown, in vitro gain/loss-of-function, co-immunoprecipitation (SIRT6-Nkx2.5), DNA damage repair assays (ATM pathway)\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP for interaction, AAV-mediated in vivo knockdown, mechanistic epistasis (SIRT6/Nkx2.5/GATA6/ATM); single lab\",\n      \"pmids\": [\"37914087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GATA-6 and NF-κB bind to specific sites on the CPI-17 promoter and upregulate CPI-17 expression in an additive manner in bladder smooth muscle cells; CPI-17 inhibits myosin light chain phosphatase, thereby regulating Ca2+ sensitization and contractile force maintenance in smooth muscle.\",\n      \"method\": \"Promoter binding assays, EMSA, GATA-6 siRNA knockdown, NF-κB KO mice, smooth muscle force measurement\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter binding assays with KO mice and functional contractility readout; single lab\",\n      \"pmids\": [\"23275439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Gain-of-function GATA6 variants (R585L, P91S, A177T) show markedly upregulated transcriptional activity in reporter assays and enhanced activation of ANP and alpha-MHC promoters when co-expressed with GATA4 and MEF2C, demonstrating that gain-of-function GATA6 mutations can drive atrial fibrillation.\",\n      \"method\": \"Whole exome sequencing, luciferase reporter assay with wild-type and mutant GATA6 constructs, co-expression with GATA4/MEF2C\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reporter assay establishing gain-of-function for three variants; single lab\",\n      \"pmids\": [\"27756709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"REG4 is a direct transcriptional target of GATA6; GATA6-mediated activation of REG4 enhances adherent growth of colon cancer cells, while LGR5 activation by GATA6 drives clonogenicity, with both being suppressed by miR-363 targeting of GATA6.\",\n      \"method\": \"GATA6 overexpression/knockdown, miR-363 overexpression, gene expression analysis, colon cancer cell proliferation/tumorigenicity assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct transcriptional target identification with functional rescue; single lab\",\n      \"pmids\": [\"26387746\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GATA6 is a zinc-finger transcription factor and pioneer factor that directly binds regulatory elements of numerous target genes (HNF4, Shh, VEGF-C, MUC1, TBX3, EDN1, Wnt6, CPI-17, REG4, LGR5, Aqp5, PKM2, Cmpk2, Ccl5, GATA6 itself) to regulate cell fate decisions in endoderm, heart, pancreas, lung, skin, and macrophage lineages; its activity is modulated post-translationally by ERK1/2-mediated phosphorylation at S264 (required for autoactivation in primitive endoderm commitment) and epigenetically through EZH2-mediated H3K27 methylation and HDAC1/2-STAT3-DNMT1-dependent promoter methylation; it cooperates with NANOG, EOMES/SMAD2/3, FOXA2, NR5A1, Nkx2.2, p300, and FOG co-factors in context-specific transcriptional complexes, and its loss-of-function causes defects ranging from primitive endoderm and visceral endoderm failure to pancreatic agenesis, bicuspid aortic valve, sinus node hypoplasia, impaired β-cell insulin secretion, and loss of brown adipose tissue.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GATA6 is a zinc-finger transcription factor and chromatin pioneer factor that directs lineage commitment and tissue identity across endoderm, heart, pancreas, lung, skin, and vascular systems by binding regulatory elements of fate-determining target genes [#0, #18, #34]. In the early embryo it is essential for primitive and visceral endoderm formation, acting upstream of HNF4 and within an FGF/ERK-driven tristable network where its levels, opposed by NANOG, dictate inner cell mass fate; ERK1/2 phosphorylation at S264 drives a positive-feedback autoactivation loop required for primitive endoderm commitment [#0, #13, #14, #25]. Genome-wide, GATA6 co-binds enhancers with NANOG and then evicts epiblast factors, remodeling chromatin accessibility and enhancer-promoter contacts to activate extraembryonic-endoderm genes while repressing pluripotency genes, and it cooperates with EOMES/SMAD2/3 to license definitive endoderm [#43, #18, #28]. In organ development it acts combinatorially and dose-dependently with GATA4 in pancreatic specification and cardiovascular morphogenesis, repressing Hedgehog signaling through GATA sites in the Shh MACS1 enhancer and maintaining acinar and \\u03b2-cell identity, with haploinsufficiency producing bicuspid aortic valve via MMP9 dysregulation and sinus node hypoplasia through loss of TBX3/EDN1 activation [#11, #16, #17, #23, #26, #42]. It also governs lung alveolar type-1 differentiation and Wnt restriction, hair follicle and sebaceous duct lineage identity, and brown adipocyte development [#2, #6, #22, #46]. GATA6 expression is itself tightly controlled epigenetically\\u2014supported by p300/EP300 acetylation and TET2-deposited 5hmC, and repressed by EZH2-mediated H3K27 methylation and HDAC1/2-STAT3-DNMT1-dependent promoter hypermethylation\\u2014a circuitry that toggles the classical-versus-basal subtype switch in pancreatic cancer, where GATA6 (with HNF1A/HNF4A) suppresses EGFR signaling, EMT, and tumor progression [#35, #44, #39, #40, #41, #19, #20]. In the broader cancer setting GATA6 acts as a context-dependent activator or repressor of targets including LGR5, REG4, VEGF-C, MUC1, and PKM2 [#15, #50, #36, #37, #31]. Heterozygous loss-of-function GATA6 mutations cause human pancreatic agenesis, explained by failure of definitive endoderm entry [#28].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established GATA6 as a master upstream regulator of visceral endoderm differentiation, placing it atop a transcriptional cascade where no endoderm-specifying factor had been genetically ordered.\",\n      \"evidence\": \"GATA6-null ES cells/mice, embryoid body differentiation, and HNF4 promoter activation assay\",\n      \"pmids\": [\"9832509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define direct vs indirect target relationships genome-wide\", \"Mechanism of GATA6 chromatin engagement not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed GATA6 is a necessary mediator of cardiomyocyte hypertrophy, extending its role from development to adult cardiac stress responses.\",\n      \"evidence\": \"Adenoviral overexpression and dominant-negative GATA4-engrailed in cardiomyocytes plus transgenic mice\",\n      \"pmids\": [\"11356841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct hypertrophic target genes not delineated\", \"Dominant-negative does not distinguish GATA6 from GATA4 function\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined GATA6 as required for alveolar type-1 cell differentiation and direct activator of AT1-specific genes, expanding its lineage scope to distal lung.\",\n      \"evidence\": \"Dominant-negative GATA6-Engrailed transgenic mice and aquaporin-5 promoter trans-activation\",\n      \"pmids\": [\"11959831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dominant-negative may affect other GATA factors\", \"Endogenous GATA6 loss-of-function in lung not tested here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified GATA6 as required for pancreas specification and a physical Nkx2.2 partner, establishing tissue-specific protein interactions underlying its pancreatic role.\",\n      \"evidence\": \"Co-IP with Nkx2.2 and dominant-negative Gata6-Engrailed transgenic mice with histology\",\n      \"pmids\": [\"16887115\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP not reciprocally validated for direct binding\", \"Dominant-negative does not isolate endogenous GATA6 requirement\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Revealed a GATA4/GATA6 dosage threshold for cardiovascular gene expression, demonstrating combinatorial and redundant function between the two factors.\",\n      \"evidence\": \"Compound heterozygous mouse genetics with histology and downstream marker analysis (MEF2C, beta-MHC)\",\n      \"pmids\": [\"16847256\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of MEF2C/beta-MHC not resolved\", \"Cell-type specificity of dosage requirement not mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Connected GATA6 to Wnt signaling control in lung stem cell dynamics and to direct activation of canonical Wnt components in endoderm, defining a pathway-level node.\",\n      \"evidence\": \"Conditional lung Gata6-null mice with genetic rescue (Fzd2, beta-catenin); ChIP and reporter on Wnt6 promoter in F9 cells\",\n      \"pmids\": [\"18536717\", \"22607194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Context-dependent canonical vs non-canonical Wnt switching mechanism unclear\", \"F9 cell findings need in vivo validation\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked GATA6 to nuclear envelope integrity and genome stability via emerin, an unexpected role beyond classical lineage transcription.\",\n      \"evidence\": \"siRNA knockdown in ovarian surface epithelial cells with emerin epistasis and nuclear morphology analysis\",\n      \"pmids\": [\"19581290\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional control of emerin by GATA6 not shown by binding data\", \"Single cell-type, no in vivo confirmation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated that combined GATA4/GATA6 loss causes pancreatic agenesis through progenitor proliferation and morphogenesis failure, defining the genetic basis for human GATA6-associated pancreatic agenesis.\",\n      \"evidence\": \"Conditional double-knockout mice with histology and progenitor marker analysis (two simultaneous publications)\",\n      \"pmids\": [\"23006325\", \"23006330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes driving proliferation defect not identified here\", \"Relative GATA4 vs GATA6 contribution not separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed endothelial GATA6 directly regulates vascular tone and inflammatory genes, extending its function to vascular homeostasis.\",\n      \"evidence\": \"Endothelial-specific Gata6 conditional KO mice with pulmonary artery pressure and target gene analysis\",\n      \"pmids\": [\"23583651\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding to all named targets not all demonstrated\", \"Single lab, mechanism of inflammatory recruitment incomplete\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Quantitatively defined GATA6 as a dose-sensitive determinant of inner cell mass fate within a tristable NANOG/FGF/ERK network, resolving how PrE versus epiblast identity is set.\",\n      \"evidence\": \"Single-cell imaging and Gata6 dosage series with FGF/ERK manipulation; mathematical modeling\",\n      \"pmids\": [\"24835466\", \"25209243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target of GATA6 enacting fate switch not isolated\", \"Quantitative thresholds may be model-system specific\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified GATA6 as a crucial regulator of Shh expression in the limb bud, repressing Shh/Gli1 with FOG co-factors and acting upstream of polydactyly phenotypes.\",\n      \"evidence\": \"Conditional Gata6 KO, forced expression, ChIP, reporter assay, and Shh/Gata6 genetic epistasis\",\n      \"pmids\": [\"24415953\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of FOG-dependent repression switch not detailed\", \"How GATA6 chooses activation vs repression at different loci unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined GATA6 as a direct activator of LGR5 and REG4 in colorectal cancer, downregulated by miR-363, establishing a tumorigenicity axis.\",\n      \"evidence\": \"Overexpression/knockdown, luciferase reporter (miR-363/GATA6 3'UTR), and xenograft assays\",\n      \"pmids\": [\"24452072\", \"26387746\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ChIP binding at LGR5/REG4 promoters not all confirmed in same study\", \"Single lineage context\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed GATA6/GATA4 maintain pancreatic endoderm identity by directly repressing Hedgehog through GATA sites in the Shh MACS1 enhancer.\",\n      \"evidence\": \"Double conditional KO and MACS1 enhancer reporter with GATA-site mutagenesis\",\n      \"pmids\": [\"26932670\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous occupancy at MACS1 not shown by ChIP here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established GATA6 as a pioneer factor sufficient to reprogram cells to extraembryonic endoderm, acting as direct repressor of pluripotency genes and activator of endoderm genes.\",\n      \"evidence\": \"Inducible Gata6, reprogramming assays, ChIP-seq, and transcriptional profiling\",\n      \"pmids\": [\"26109048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of repression vs activation events not fully temporally resolved\", \"Pioneer chromatin-opening mechanism characterized later\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined GATA6 as a tumor suppressor in pancreatic cancer that directly represses EGFR and inflammatory pathways to maintain acinar identity.\",\n      \"evidence\": \"GEMMs with KrasG12V, ChIP-seq, RNA-seq, and human PDAC cell silencing\",\n      \"pmids\": [\"25596178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of repression at EGFR pathway loci not detailed\", \"Cofactors mediating repression not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed GATA6 inhibits EMT and dissemination in PDAC through direct and indirect transcriptional control of EMT genes, reinforcing its differentiation-maintaining role.\",\n      \"evidence\": \"Gain/loss-of-function in PDAC cells, ChIP-seq, RNA-seq, in vivo dissemination\",\n      \"pmids\": [\"27325420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Indirect EMT TF regulation not fully mapped\", \"Patient-stratification implications not tested clinically\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified gain-of-function GATA6 variants that enhance transcriptional activity and can drive atrial fibrillation, complementing loss-of-function disease mechanisms.\",\n      \"evidence\": \"Whole exome sequencing and reporter assays with GATA4/MEF2C co-expression\",\n      \"pmids\": [\"27756709\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reporter assay does not establish in vivo arrhythmogenic mechanism\", \"Limited to three variants, single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined GATA6 control of hair follicle matrix progenitor renewal via Edaradd/NF-kB to protect proliferating cells from DNA damage, extending its role to epidermal stem cells.\",\n      \"evidence\": \"Conditional KO and keratinocyte rescue with Edaradd; DNA damage assays\",\n      \"pmids\": [\"27908934\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct GATA6 binding at Edaradd not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established GATA6 as the lineage-identity determinant of the sebaceous duct and a driver of cellular dedifferentiation and self-renewal during wound healing.\",\n      \"evidence\": \"Conditional KO, lineage tracing, live imaging, clonogenic assays\",\n      \"pmids\": [\"28504705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets enforcing SD identity not defined\", \"Mechanism of dedifferentiation gain unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined GATA6 as required for adult \\u03b2-cell insulin biosynthesis and secretion, acting through GATA-dependent Pdx1 expression.\",\n      \"evidence\": \"Pancreas-specific KO with glucose tolerance, insulin assays, EM, and GATA-site mutant reporter mice\",\n      \"pmids\": [\"29263149\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full \\u03b2-cell target gene network not mapped\", \"Direct vs indirect Pdx1 regulation partially resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed GATA6 cooperates with Sp1 and p300 to activate Aqp5 via histone acetylation, competing with HDAC3, illustrating its coactivator-recruitment mechanism.\",\n      \"evidence\": \"Co-IP (GATA6/Sp1/p300/HDAC3), ChIP for acetylation, and reporter assays\",\n      \"pmids\": [\"28615712\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP interactions not reciprocally validated for direct contact\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Implicated GATA6 with NR5A1 in steroidogenesis in endometriotic cells, broadening its role to local estrogen production in disease.\",\n      \"evidence\": \"Ectopic expression and siRNA of GATA6/NR5A1 with estradiol output assays\",\n      \"pmids\": [\"29402198\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter binding at steroidogenic genes not shown\", \"Single lab, in vitro only\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved how GATA6 sustains its own expression: ERK1/2 phosphorylation at S264 enables autoactivation, providing the post-translational switch for primitive endoderm commitment.\",\n      \"evidence\": \"Gata6-H2BGFP knock-in mouse, S264 site-directed mutagenesis, and promoter activation assay\",\n      \"pmids\": [\"29454706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct demonstration of ERK phosphorylation at S264 in vivo limited\", \"Other phosphosites not surveyed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the precise cellular requirement for GATA6 in bicuspid aortic valve via secondary-heart-field myocytes and MMP9-dependent valve remodeling, with human genetic validation.\",\n      \"evidence\": \"Haploinsufficient and cell-specific conditional KO mice, MMP9 analysis, human GWAS\",\n      \"pmids\": [\"29567669\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GATA6 regulation of MMP9 not shown by binding\", \"Mechanism of ECM dysregulation incomplete\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed GATA6 cooperates genome-wide with EOMES/SMAD2/3 to license definitive endoderm, mechanistically explaining human heterozygous GATA6 pancreatic agenesis.\",\n      \"evidence\": \"Isogenic and patient-derived hPSCs, directed differentiation, ChIP-seq of three factors, RNA-seq\",\n      \"pmids\": [\"30629940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dosage threshold for human DE entry not precisely quantified\", \"Cooperative complex assembly mechanism not structurally resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Expanded the GATA6 cancer target repertoire (CD137L, miR-520b/CREB1, PKM2) and showed context-dependent activator/repressor behavior across tumor types.\",\n      \"evidence\": \"ChIP, reporter assays, knockdown/overexpression, in vivo metastasis/tumorigenicity models\",\n      \"pmids\": [\"30194255\", \"30674866\", \"30834518\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cofactors determining activation vs repression at these loci unknown\", \"Each target validated in single tumor context\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated GATA6 is itself repressed by GATA4 through proximal repressive sites, revealing cross-regulation between the two GATA factors in heart development.\",\n      \"evidence\": \"ChIP-qPCR, reporter assay, and Gata4 heterozygous mice\",\n      \"pmids\": [\"31120883\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of GATA4-mediated repression unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified a GATA6-LOXL2 physical complex driving VEGFA-dependent angiogenesis, an example of non-transcription-factor partnership.\",\n      \"evidence\": \"Co-IP, RT-qPCR, ELISA, tube formation, xenograft in cholangiocarcinoma\",\n      \"pmids\": [\"31322171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP not reciprocally confirmed for direct binding\", \"How LOXL2 modulates GATA6 activity unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Characterized GATA6 as a cardiac pioneer factor regulating SMYD1/HAND2/KDR for outflow tract formation, and showed a missense variant confers ectopic pioneer activity altering lineage output.\",\n      \"evidence\": \"Isogenic iPSC cardiomyocytes, RNA-seq, ATAC-seq, ChIP-seq comparing LoF and missense variants\",\n      \"pmids\": [\"33054971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of ectopic pioneer activity of missense variant not fully defined\", \"In vivo correlate of iPSC findings limited\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established that GATA6 expression is epigenetically silenced by EZH2 (H3K27me) to enforce the basal PDAC program, with GATA6 re-ablation confirming its functional importance.\",\n      \"evidence\": \"EZH2 ChIP-seq at GATA6 locus, RNA-seq, and epistatic GATA6 knockdown in EZH2-deficient cells\",\n      \"pmids\": [\"32907838\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger for EZH2 recruitment to GATA6 locus unknown\", \"Reversibility window in patients untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified additional context-dependent GATA6 repression targets (VEGF-C in bladder cancer, MUC1/beta-catenin axis in cholangiocarcinoma) and dose-sensitive lung-versus-liver fate control.\",\n      \"evidence\": \"ChIP, reporter mutagenesis, Co-IP, knockdown/overexpression, in vivo metastasis; hPSC lung differentiation\",\n      \"pmids\": [\"32103545\", \"33060563\", \"29889101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Switch between activator and repressor function not mechanistically explained\", \"Each target in single tissue context\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined a GATA6/HNF1A/HNF4A regulatory network controlling PDAC subtype identity, showing GATA6 loss is necessary but not sufficient for the basal switch.\",\n      \"evidence\": \"Dual-recombinase late-deletion mouse model, RNA-seq, human transcriptomics validation\",\n      \"pmids\": [\"33846140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy among GATA6, HNF1A, HNF4A not fully ordered\", \"Therapeutic exploitation not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed epigenetic control of GATA6 levels in vascular and tumor contexts: HDAC1/2-STAT3-DNMT1 promoter hypermethylation represses it, while TET2-deposited 5hmC (SMAD4-supported) maintains it.\",\n      \"evidence\": \"MSP, ChIP, Co-IP, STAT3 K685 mutation, oxidative bisulfite sequencing, in vivo pharmacological rescue\",\n      \"pmids\": [\"33859766\", \"33915173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cross-talk between activating and repressive marks at GATA6 locus unresolved\", \"Single lab per mechanism\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved the pioneer mechanism: GATA6 co-binds enhancers with NANOG then evicts epiblast factors and remodels chromatin and enhancer-promoter contacts to flip ICM cells to PrE fate.\",\n      \"evidence\": \"Inducible GATA6 ES cells and blastocysts, ChIP-seq, ATAC-seq, Hi-C/4C\",\n      \"pmids\": [\"35871075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger for epiblast-TF eviction not identified\", \"Kinetics of chromatin remodeling at single-cell level limited\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified EP300/p300 as a direct positive regulator of GATA6 expression whose loss drives the classical-to-basal PDAC switch and Wnt-inhibitor resistance.\",\n      \"evidence\": \"In vivo CRISPR screen, EP300 KO, GATA6 overexpression rescue, RNA-seq, chromatin accessibility\",\n      \"pmids\": [\"35536676\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EP300 acts directly at GATA6 locus vs broadly not fully resolved\", \"Clinical reversal strategy untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established GATA6 as a direct activator of the sinus node program through TBX3 and EDN1, with haploinsufficiency causing hypoplastic sinus node and arrhythmia.\",\n      \"evidence\": \"Haploinsufficient and cell-specific KO mice, ECG, histology, chromatin binding and activation assays\",\n      \"pmids\": [\"33443158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lineage-specific cofactors at TBX3/EDN1 not defined\", \"Human relevance via genetics not tested here\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended GATA6 roles to vascular inflammation/atherosclerosis (direct Cmpk2/Ccl5 targets via CMPK2-Nlrp3), brown adipocyte development, and vascular calcification (SIRT6-Nkx2.5-GATA6-ATM axis).\",\n      \"evidence\": \"Cell-specific KO, ChIP, AAV knockdown/rescue, lineage tracing, single-cell RNA-seq, Co-IP\",\n      \"pmids\": [\"37339559\", \"37647897\", \"37914087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding for all named targets not uniformly demonstrated\", \"Each context single lab\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed GATA6 with NF-kB activates CPI-17 in smooth muscle to regulate calcium sensitization and contractile force, a role in smooth muscle physiology.\",\n      \"evidence\": \"Promoter binding assays, EMSA, GATA6 siRNA, NF-kB KO mice, force measurement\",\n      \"pmids\": [\"23275439\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Additive vs cooperative mechanism with NF-kB not fully dissected\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GATA6 switches between transcriptional activation and repression at different loci, and what cofactor/chromatin context dictates pioneer versus classical TF behavior, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying rule for activator-vs-repressor target selection\", \"Structural basis of GATA6 cofactor complexes not determined\", \"Post-translational modifications beyond S264 not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 18, 19, 28, 34, 42, 43]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [8, 9, 17, 30, 31, 36, 37]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [9, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [18, 43, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 11, 13, 17, 26, 42, 46]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 18, 28, 34, 43]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [19, 20, 35, 41, 44]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [35, 43, 44]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 13, 14, 25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GATA4\", \"NANOG\", \"EOMES\", \"SMAD2\", \"FOXA2\", \"NR5A1\", \"SP1\", \"EP300\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}